WO2022078306A1 - Large steric hinderance palladium-nitrogen-heterocyclic carbene complex, preparation method for same, applications of same, and synthesis method for sonidegib based on same - Google Patents
Large steric hinderance palladium-nitrogen-heterocyclic carbene complex, preparation method for same, applications of same, and synthesis method for sonidegib based on same Download PDFInfo
- Publication number
- WO2022078306A1 WO2022078306A1 PCT/CN2021/123160 CN2021123160W WO2022078306A1 WO 2022078306 A1 WO2022078306 A1 WO 2022078306A1 CN 2021123160 W CN2021123160 W CN 2021123160W WO 2022078306 A1 WO2022078306 A1 WO 2022078306A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- substituted
- unsubstituted
- reaction
- palladium
- sterically hindered
- Prior art date
Links
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 title claims abstract description 75
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 238000001308 synthesis method Methods 0.000 title abstract description 13
- VZZJRYRQSPEMTK-CALCHBBNSA-N sonidegib Chemical compound C1[C@@H](C)O[C@@H](C)CN1C(N=C1)=CC=C1NC(=O)C1=CC=CC(C=2C=CC(OC(F)(F)F)=CC=2)=C1C VZZJRYRQSPEMTK-CALCHBBNSA-N 0.000 title abstract description 7
- 229960005325 sonidegib Drugs 0.000 title abstract description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims abstract description 171
- 229910052763 palladium Inorganic materials 0.000 claims abstract description 76
- 230000003197 catalytic effect Effects 0.000 claims abstract description 46
- 238000005859 coupling reaction Methods 0.000 claims abstract description 46
- 239000003446 ligand Substances 0.000 claims abstract description 41
- 238000006555 catalytic reaction Methods 0.000 claims abstract description 19
- 125000003118 aryl group Chemical group 0.000 claims abstract description 17
- 239000000126 substance Substances 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 9
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 4
- 150000001500 aryl chlorides Chemical class 0.000 claims abstract description 3
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000000376 reactant Substances 0.000 claims abstract description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 119
- 238000006243 chemical reaction Methods 0.000 claims description 87
- 229910052757 nitrogen Inorganic materials 0.000 claims description 60
- 125000000623 heterocyclic group Chemical group 0.000 claims description 59
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 52
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 33
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 26
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 claims description 26
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 25
- 150000001875 compounds Chemical class 0.000 claims description 24
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 23
- 239000002904 solvent Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 14
- PONXTPCRRASWKW-KBPBESRZSA-N diphenylethylenediamine Chemical class C1([C@H](N)[C@@H](N)C=2C=CC=CC=2)=CC=CC=C1 PONXTPCRRASWKW-KBPBESRZSA-N 0.000 claims description 13
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 11
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 10
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 claims description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 10
- 238000006467 substitution reaction Methods 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 9
- 239000001257 hydrogen Substances 0.000 claims description 9
- 239000007858 starting material Substances 0.000 claims description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 claims description 8
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 8
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 8
- 150000002940 palladium Chemical class 0.000 claims description 7
- 230000035484 reaction time Effects 0.000 claims description 7
- 125000006651 (C3-C20) cycloalkyl group Chemical group 0.000 claims description 6
- 229910018286 SbF 6 Inorganic materials 0.000 claims description 6
- 235000010290 biphenyl Nutrition 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- IVSZLXZYQVIEFR-UHFFFAOYSA-N m-xylene Chemical group CC1=CC=CC(C)=C1 IVSZLXZYQVIEFR-UHFFFAOYSA-N 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 5
- QEOQKWIURDCGIJ-UHFFFAOYSA-N 2-bromo-1,3-di(propan-2-yl)benzene Chemical class CC(C)C1=CC=CC(C(C)C)=C1Br QEOQKWIURDCGIJ-UHFFFAOYSA-N 0.000 claims description 5
- 238000006069 Suzuki reaction reaction Methods 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 5
- 238000006482 condensation reaction Methods 0.000 claims description 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 5
- 150000004693 imidazolium salts Chemical group 0.000 claims description 5
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 claims description 5
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 claims description 5
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 4
- BJGKVCKGUBYULR-UHFFFAOYSA-N 3-bromo-2-methylbenzoic acid Chemical compound CC1=C(Br)C=CC=C1C(O)=O BJGKVCKGUBYULR-UHFFFAOYSA-N 0.000 claims description 4
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 4
- HUOFUOCSQCYFPW-UHFFFAOYSA-N [4-(trifluoromethoxy)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(OC(F)(F)F)C=C1 HUOFUOCSQCYFPW-UHFFFAOYSA-N 0.000 claims description 4
- 239000012670 alkaline solution Substances 0.000 claims description 4
- 239000004305 biphenyl Substances 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 150000002460 imidazoles Chemical class 0.000 claims description 4
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- QAJYCQZQLVENRZ-UHFFFAOYSA-N 6-chloropyridin-3-amine Chemical compound NC1=CC=C(Cl)N=C1 QAJYCQZQLVENRZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 3
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 229910000160 potassium phosphate Inorganic materials 0.000 claims description 3
- 235000011009 potassium phosphates Nutrition 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 238000010189 synthetic method Methods 0.000 claims description 3
- 101150003085 Pdcl gene Proteins 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims description 2
- 150000005347 biaryls Chemical class 0.000 claims description 2
- ZDZHCHYQNPQSGG-UHFFFAOYSA-N binaphthyl group Chemical group C1(=CC=CC2=CC=CC=C12)C1=CC=CC2=CC=CC=C12 ZDZHCHYQNPQSGG-UHFFFAOYSA-N 0.000 claims description 2
- 150000004074 biphenyls Chemical class 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 150000002475 indoles Chemical class 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 125000003860 C1-C20 alkoxy group Chemical group 0.000 claims 2
- RUAFPCMISXUGHL-UHFFFAOYSA-N 1,1'-biphenyl;phosphane Chemical compound P.C1=CC=CC=C1C1=CC=CC=C1 RUAFPCMISXUGHL-UHFFFAOYSA-N 0.000 claims 1
- HNVIQLPOGUDBSU-UHFFFAOYSA-N 2,6-dimethylmorpholine Chemical compound CC1CNCC(C)O1 HNVIQLPOGUDBSU-UHFFFAOYSA-N 0.000 claims 1
- RRGSSVBWRDTNFM-UHFFFAOYSA-N 2-methyl-3-[2-(trifluoromethoxy)phenyl]benzoic acid Chemical compound CC1=C(C(O)=O)C=CC=C1C1=CC=CC=C1OC(F)(F)F RRGSSVBWRDTNFM-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 150000001298 alcohols Chemical class 0.000 claims 1
- 125000000609 carbazolyl group Chemical class C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 claims 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 claims 1
- 229910001948 sodium oxide Inorganic materials 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 abstract description 45
- 239000003054 catalyst Substances 0.000 abstract description 38
- 229910052751 metal Inorganic materials 0.000 abstract description 10
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract description 8
- CPHGOBGXZQKCKI-UHFFFAOYSA-N 4,5-diphenyl-1h-imidazole Chemical compound N1C=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 CPHGOBGXZQKCKI-UHFFFAOYSA-N 0.000 abstract description 5
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 78
- 230000015572 biosynthetic process Effects 0.000 description 43
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 42
- -1 N-heterocyclic carbene palladium complexes Chemical class 0.000 description 34
- 239000000047 product Substances 0.000 description 32
- 238000005481 NMR spectroscopy Methods 0.000 description 28
- 230000002829 reductive effect Effects 0.000 description 27
- 238000010898 silica gel chromatography Methods 0.000 description 26
- 239000007787 solid Substances 0.000 description 26
- 239000003480 eluent Substances 0.000 description 18
- 239000012299 nitrogen atmosphere Substances 0.000 description 18
- 239000003208 petroleum Substances 0.000 description 18
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 14
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 description 14
- 230000008878 coupling Effects 0.000 description 12
- 238000010168 coupling process Methods 0.000 description 12
- 150000004985 diamines Chemical class 0.000 description 12
- 238000009776 industrial production Methods 0.000 description 12
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 9
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000005984 hydrogenation reaction Methods 0.000 description 8
- 239000000543 intermediate Substances 0.000 description 8
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 8
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 235000019253 formic acid Nutrition 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000012043 crude product Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000006464 oxidative addition reaction Methods 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 5
- 238000004611 spectroscopical analysis Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- YLEIFZAVNWDOBM-ZTNXSLBXSA-N ac1l9hc7 Chemical compound C([C@H]12)C[C@@H](C([C@@H](O)CC3)(C)C)[C@@]43C[C@@]14CC[C@@]1(C)[C@@]2(C)C[C@@H]2O[C@]3(O)[C@H](O)C(C)(C)O[C@@H]3[C@@H](C)[C@H]12 YLEIFZAVNWDOBM-ZTNXSLBXSA-N 0.000 description 4
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000004896 high resolution mass spectrometry Methods 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 3
- OQDPVLVUJFGPGQ-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]pyrimidine Chemical compound C=1C=C2OCOC2=CC=1CN(CC1)CCN1C1=NC=CC=N1 OQDPVLVUJFGPGQ-UHFFFAOYSA-N 0.000 description 3
- 206010004146 Basal cell carcinoma Diseases 0.000 description 3
- 239000004593 Epoxy Substances 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229940125782 compound 2 Drugs 0.000 description 3
- 125000006575 electron-withdrawing group Chemical group 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 150000007529 inorganic bases Chemical class 0.000 description 3
- 229960004310 piribedil Drugs 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000009790 rate-determining step (RDS) Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- VLPBNQMPKNGOJC-DTORHVGOSA-N 6-[(2r,6s)-2,6-dimethylmorpholin-4-yl]pyridin-3-amine Chemical compound C1[C@@H](C)O[C@@H](C)CN1C1=CC=C(N)C=N1 VLPBNQMPKNGOJC-DTORHVGOSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- CYSWUSAYJNCAKA-FYJFLYSWSA-N ClC1=C(C=CC=2N=C(SC=21)OCC)OC1=CC=C(C=N1)/C=C/[C@H](C)NC(C)=O Chemical compound ClC1=C(C=CC=2N=C(SC=21)OCC)OC1=CC=C(C=N1)/C=C/[C@H](C)NC(C)=O CYSWUSAYJNCAKA-FYJFLYSWSA-N 0.000 description 2
- QBXVXKRWOVBUDB-GRKNLSHJSA-N ClC=1C(=CC(=C(CN2[C@H](C[C@H](C2)O)C(=O)O)C1)OCC1=CC(=CC=C1)C#N)OCC1=C(C(=CC=C1)C1=CC2=C(OCCO2)C=C1)C Chemical compound ClC=1C(=CC(=C(CN2[C@H](C[C@H](C2)O)C(=O)O)C1)OCC1=CC(=CC=C1)C#N)OCC1=C(C(=CC=C1)C1=CC2=C(OCCO2)C=C1)C QBXVXKRWOVBUDB-GRKNLSHJSA-N 0.000 description 2
- 239000005517 L01XE01 - Imatinib Substances 0.000 description 2
- 239000005536 L01XE08 - Nilotinib Substances 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- SRVFFFJZQVENJC-IHRRRGAJSA-N aloxistatin Chemical compound CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C SRVFFFJZQVENJC-IHRRRGAJSA-N 0.000 description 2
- 150000001502 aryl halides Chemical class 0.000 description 2
- 125000006267 biphenyl group Chemical group 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 description 2
- 229960002411 imatinib Drugs 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- QAPTWHXHEYAIKG-RCOXNQKVSA-N n-[(1r,2s,5r)-5-(tert-butylamino)-2-[(3s)-2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide Chemical compound CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1C(=O)[C@@H](NC=2C3=CC(=CC=C3N=CN=2)C(F)(F)F)CC1 QAPTWHXHEYAIKG-RCOXNQKVSA-N 0.000 description 2
- HHZIURLSWUIHRB-UHFFFAOYSA-N nilotinib Chemical compound C1=NC(C)=CN1C1=CC(NC(=O)C=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 HHZIURLSWUIHRB-UHFFFAOYSA-N 0.000 description 2
- 229960001346 nilotinib Drugs 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 238000006894 reductive elimination reaction Methods 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- PSXXQPXVGFIBMQ-KBPBESRZSA-N (1S,2S)-1-(4-nitrophenyl)-2-phenylethane-1,2-diamine Chemical compound C1=CC=C(C=C1)[C@@H]([C@H](C2=CC=C(C=C2)[N+](=O)[O-])N)N PSXXQPXVGFIBMQ-KBPBESRZSA-N 0.000 description 1
- XSUOYNMDPIEXBN-ROUUACIJSA-N (1s,2s)-1,2-bis[4-(dimethylamino)phenyl]ethane-1,2-diamine Chemical compound C1=CC(N(C)C)=CC=C1[C@H](N)[C@@H](N)C1=CC=C(N(C)C)C=C1 XSUOYNMDPIEXBN-ROUUACIJSA-N 0.000 description 1
- HNVIQLPOGUDBSU-OLQVQODUSA-N (2s,6r)-2,6-dimethylmorpholine Chemical compound C[C@H]1CNC[C@@H](C)O1 HNVIQLPOGUDBSU-OLQVQODUSA-N 0.000 description 1
- PONXTPCRRASWKW-UHFFFAOYSA-N 1,2-diphenylethane-1,2-diamine Chemical compound C=1C=CC=CC=1C(N)C(N)C1=CC=CC=C1 PONXTPCRRASWKW-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- FUMMYHVKFAHQST-UHFFFAOYSA-N 2-bromo-1,3,5-tri(propan-2-yl)benzene Chemical compound CC(C)C1=CC(C(C)C)=C(Br)C(C(C)C)=C1 FUMMYHVKFAHQST-UHFFFAOYSA-N 0.000 description 1
- GOOCAVRDXRFLAW-UHFFFAOYSA-N 2-bromo-5-methoxy-1,3-di(propan-2-yl)benzene Chemical compound CC(C)C1=CC(=CC(=C1Br)C(C)C)OC GOOCAVRDXRFLAW-UHFFFAOYSA-N 0.000 description 1
- BAZVFQBTJPBRTJ-UHFFFAOYSA-N 2-chloro-5-nitropyridine Chemical compound [O-][N+](=O)C1=CC=C(Cl)N=C1 BAZVFQBTJPBRTJ-UHFFFAOYSA-N 0.000 description 1
- LNRROOUNLXDADK-UHFFFAOYSA-N 2-methyl-3-[4-(trifluoromethoxy)phenyl]benzoic acid Chemical compound CC1=C(C(O)=O)C=CC=C1C1=CC=C(OC(F)(F)F)C=C1 LNRROOUNLXDADK-UHFFFAOYSA-N 0.000 description 1
- MWVKLRSIDOXBSE-UHFFFAOYSA-N 5-(1-piperidin-4-ylpyrazol-4-yl)-3-(6-pyrrolidin-1-yl-1,3-benzoxazol-2-yl)pyridin-2-amine Chemical compound NC1=NC=C(C2=CN(N=C2)C2CCNCC2)C=C1C(OC1=C2)=NC1=CC=C2N1CCCC1 MWVKLRSIDOXBSE-UHFFFAOYSA-N 0.000 description 1
- ADLVDYMTBOSDFE-UHFFFAOYSA-N 5-chloro-6-nitroisoindole-1,3-dione Chemical compound C1=C(Cl)C([N+](=O)[O-])=CC2=C1C(=O)NC2=O ADLVDYMTBOSDFE-UHFFFAOYSA-N 0.000 description 1
- UGSBCCAHDVCHGI-UHFFFAOYSA-N 5-nitropyridin-2-amine Chemical compound NC1=CC=C([N+]([O-])=O)C=N1 UGSBCCAHDVCHGI-UHFFFAOYSA-N 0.000 description 1
- PLQFCJIRQJGPHR-UHFFFAOYSA-N 6-nitropyridin-3-amine Chemical compound NC1=CC=C([N+]([O-])=O)N=C1 PLQFCJIRQJGPHR-UHFFFAOYSA-N 0.000 description 1
- VCUKKMIXURRDKL-UHFFFAOYSA-N 9-(dimethylamino)-3-(4-ethylphenyl)pyrido[1,2]thieno[3,4-d]pyrimidin-4-one Chemical compound C1=CC(CC)=CC=C1N1C(=O)C(SC=2C3=C(N(C)C)C=CN=2)=C3N=C1 VCUKKMIXURRDKL-UHFFFAOYSA-N 0.000 description 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000027355 Ferocactus setispinus Species 0.000 description 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- PTRVNXFOPOCXPE-UHFFFAOYSA-N N-(6-aminopyridin-3-yl)-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide Chemical compound NC1=CC=C(C=N1)NC(=O)C=1C(=C(C=CC=1)C1=CC=C(C=C1)OC(F)(F)F)C PTRVNXFOPOCXPE-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- BEXZJJQVPWJPOA-VOTSOKGWSA-N [(e)-hept-2-enyl] 6-methyl-4-(4-nitrophenyl)-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxylate Chemical compound CCCC\C=C\COC(=O)C1=C(C)NC(=O)NC1C1=CC=C([N+]([O-])=O)C=C1 BEXZJJQVPWJPOA-VOTSOKGWSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- TWKVUTXHANJYGH-UHFFFAOYSA-L allyl palladium chloride Chemical class Cl[Pd]CC=C.Cl[Pd]CC=C TWKVUTXHANJYGH-UHFFFAOYSA-L 0.000 description 1
- 125000000746 allylic group Chemical group 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 229940035678 anti-parkinson drug Drugs 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- YCNIBOIOWCTRCL-UHFFFAOYSA-N azane;2,2,2-trifluoroacetic acid Chemical compound [NH4+].[O-]C(=O)C(F)(F)F YCNIBOIOWCTRCL-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- ZKIAIYBUSXZPLP-UHFFFAOYSA-N brexpiprazole Chemical compound C1=C2NC(=O)C=CC2=CC=C1OCCCCN(CC1)CCN1C1=CC=CC2=C1C=CS2 ZKIAIYBUSXZPLP-UHFFFAOYSA-N 0.000 description 1
- 229960001210 brexpiprazole Drugs 0.000 description 1
- 229940015273 buspar Drugs 0.000 description 1
- QWCRAEMEVRGPNT-UHFFFAOYSA-N buspirone Chemical compound C1C(=O)N(CCCCN2CCN(CC2)C=2N=CC=CN=2)C(=O)CC21CCCC2 QWCRAEMEVRGPNT-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001716 carbazoles Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000007036 catalytic synthesis reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 150000001924 cycloalkanes Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 125000005266 diarylamine group Chemical group 0.000 description 1
- AVAACINZEOAHHE-VFZPANTDSA-N doripenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](CNS(N)(=O)=O)C1 AVAACINZEOAHHE-VFZPANTDSA-N 0.000 description 1
- DYLUUSLLRIQKOE-UHFFFAOYSA-N enasidenib Chemical compound N=1C(C=2N=C(C=CC=2)C(F)(F)F)=NC(NCC(C)(O)C)=NC=1NC1=CC=NC(C(F)(F)F)=C1 DYLUUSLLRIQKOE-UHFFFAOYSA-N 0.000 description 1
- 229950010133 enasidenib Drugs 0.000 description 1
- BMWJQXGRRAAJNA-UHFFFAOYSA-N ethane-1,2-diol;1,2-xylene Chemical compound OCCO.CC1=CC=CC=C1C BMWJQXGRRAAJNA-UHFFFAOYSA-N 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- 150000002214 flavonoid derivatives Chemical class 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 150000005232 imidazopyridines Chemical class 0.000 description 1
- 229940116871 l-lactate Drugs 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- OCIDXARMXNJACB-UHFFFAOYSA-N n'-phenylethane-1,2-diamine Chemical compound NCCNC1=CC=CC=C1 OCIDXARMXNJACB-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005694 sulfonylation reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/006—Palladium compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2265—Carbenes or carbynes, i.e.(image)
- B01J31/2269—Heterocyclic carbenes
- B01J31/2273—Heterocyclic carbenes with only nitrogen as heteroatomic ring members, e.g. 1,3-diarylimidazoline-2-ylidenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/04—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
- C07C209/06—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms
- C07C209/10—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms with formation of amino groups bound to carbon atoms of six-membered aromatic rings or from amines having nitrogen atoms bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/023—Preparation; Separation; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
- B01J2231/42—Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
- B01J2231/4277—C-X Cross-coupling, e.g. nucleophilic aromatic amination, alkoxylation or analogues
- B01J2231/4283—C-X Cross-coupling, e.g. nucleophilic aromatic amination, alkoxylation or analogues using N nucleophiles, e.g. Buchwald-Hartwig amination
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/824—Palladium
Definitions
- the invention belongs to the technical field of organic synthesis and chemical catalysis, and in particular relates to a large sterically hindered nitrogen heterocyclic carbene palladium complex and a preparation method thereof and its application in efficient catalysis of C-N coupling reaction at room temperature, and a sony Gibb based on the same synthetic method.
- Phosphine ligands and nitrogen heterocyclic carbene (NHC) ligands are both strong electron-donating ligands, and their palladium complexes can efficiently catalyze oxidative addition rate-determining reactions, but they have great differences in steric structures. .
- Arduengo successfully isolated the nitrogen heterocyclic free carbene for the first time; in 1997, Tolman et al. conducted in-depth research on the steric structure of phosphine ligands, and believed that the steric structure of phosphine ligands was conical in shape, with large steric substitution on P. The group is far away from the metal active center, cannot wrap the metal center well, and lacks stability.
- the nitrogen heterocyclic carbene ligand is just the opposite, the substituent on the N-aromatic ring is in a pendant state, and the distance from the metal center is closer, which makes the catalyst more stable, and it is not easy to generate palladium black, so it can be used in air or even in water. efficient catalysis in the system.
- the research on N-heterocyclic carbene metal complexes has developed rapidly and has become a research hotspot in the field of metal-organic catalysis, especially the C-C, C-O, C-N coupling catalyzed by N-heterocyclic carbene palladium complexes The response and so on have been fruitful.
- transition metal-catalyzed C-N bond formation reaction has a profound impact on the synthesis of nitrogen-containing molecules, especially the palladium-catalyzed amination of aryl halides, which has become a very valuable tool in industrial production and academic research, and is widely used in Synthesis and modification of functional compounds such as medicines, pesticides and functional materials.
- Sonidegib English name Sonidegib, is a SMO receptor antagonist developed by Novartis and approved by FDA and EMA on July 24, 2015 and August 14, 2015, respectively. Inhibits the Hedgehog pathway, thereby preventing or reducing the development of cancer.
- Sonnygib is used to treat patients with locally advanced basal cell carcinoma who are inoperable and inoperable with radiation therapy, or who have recurred after surgery or radiation therapy.
- the drug is currently one of only two marketed drugs for the treatment of basal cell carcinoma.
- the synthetic routes of Sony Gibb mainly include the following:
- Patent document WO2017163258 reports a method similar to the above-mentioned route 1, the difference is that it first performs Suzuki coupling to obtain biphenyl intermediates, and then performs condensation acylation to obtain the target product Sony Gibb, and the total yield is 63.1%.
- Patent document CN105330658A reported a new route, through the intermolecular condensation reaction of industrial raw material L-lactate to obtain cis-2R, 2'S-bis (propionate) ether, the intermediate is then subjected to reduction reaction, sulfonylation Reaction and cyclization with N-(6-aminopyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide , the Sony Gibb was obtained with a total yield of 15.1%.
- Patent document CN109293649A reported another new route, utilizing 2-amino-5-nitropyridine and R-epoxy propylene (or S-epoxy propylene) through epoxy ring-opening substitution reaction, and then through condensation reaction to prepare Sony Gibb Intermediates.
- the intermediate is reduced by catalytic hydrogenation to obtain (2S,6R)-2,6-dimethyl-4-(5-aminopyridin-2-yl)morpholine, 2-methyl-4'-( Trifluoromethoxy)-[1,1'-biphenyl]-3-carboxylic acid and acid chloride reagent were subjected to acid chloride reaction, and then reacted with the above (2S,6R)-2,6-dimethyl-4-(5 -Aminopyridin-2-yl)morpholine was prepared by amidation reaction of Sonnigib with a total yield of 58.5%.
- the primary purpose of the present invention is to provide a large sterically hindered nitrogen heterocyclic carbene palladium complex.
- the large sterically hindered nitrogen heterocyclic carbene palladium complex structure of the present invention takes diphenylimidazole as the main ligand skeleton and the functionalized allyl group as the auxiliary ligand, has significantly improved catalytic activity and stability, and is applied to catalysis
- the C-N coupling reaction of aromatic heterocyclic chlorides realizes the efficient catalytic C-N coupling of aromatic heterocyclic chlorides at room temperature, and the yield can be as high as 99%.
- Another object of the present invention is to provide a preparation method of the above-mentioned large sterically hindered nitrogen heterocyclic carbene palladium complex.
- the large sterically hindered nitrogen heterocyclic carbene palladium complex of the present invention takes the large sterically hindered imidazolium salt substituted by phenyl as the skeleton, and is carried out with the functionalized palladium dimer [Pd-(allyl-R 3 )(uX)] 2 It is obtained by coordination, more specifically, substituted or unsubstituted diphenylethylenediamine is used as the starting material, and the target product can be obtained through three to four chemical reactions.
- the synthesis method is simple, economical, and suitable for industrial production.
- Another object of the present invention is to provide the application of the above-mentioned large sterically hindered nitrogen heterocyclic carbene palladium complex in the efficient catalysis of C-N coupling reaction, especially the C-N coupling reaction can be efficiently catalyzed at room temperature.
- Another object of the present invention is to provide a method for synthesizing a sonny Gibb.
- the synthesis method of the invention is a three-step synthesis to obtain the target product, which not only has few synthesis steps and high yield, avoids the palladium-carbon hydrogenation process, but also can carry out the reaction at room temperature, thereby being safer and lower in cost, and suitable for industrialization mass production.
- the large sterically hindered nitrogen heterocyclic carbene palladium complex of the present invention is used, a remarkably improved yield of the reaction at room temperature can be obtained.
- a large sterically hindered nitrogen heterocyclic carbene palladium complex (NHC-Pd complex), the complex is a compound having the chemical structural formula shown in formula (A) or its enantiomer (B) or racemate (C) ):
- R 1 , R 1' , R 2 , R 2' which are the same or different are hydrogen, substituted or unsubstituted C6-20 aryl, substituted or unsubstituted C4-20 heterocyclyl, substituted or unsubstituted C4-20 heterocyclic group, respectively.
- R 3 is hydrogen, substituted or unsubstituted C6-20 aryl, substituted or unsubstituted C4-20 heterocyclyl, substituted or unsubstituted C1-20 alkyl, substituted or unsubstituted C3-20 Any of the cycloalkyl and substituted amino groups;
- X may be one of -Cl, -Br, -I, CH 3 COO-, CF 3 COO-, -BF 4 , -PF 6 , -SbF 6 , -OTf.
- substitutions mentioned above mean that one or more hydrogen atoms in the group can be replaced by C6-20 aryl, C4-20 heterocyclic, C1-20 hydrocarbyloxy, C1-20 alkyl, Substitution of C3-20 cycloalkyl, -CF 3 , -NO 2 , halogen group and the like.
- the structure of the large sterically hindered nitrogen heterocyclic carbene palladium complex of the present invention takes diphenylimidazole as the main ligand skeleton and the functionalized allyl group as the auxiliary ligand.
- the functionalized allyl group next to the metal center of the catalyst as the auxiliary ligand.
- the ligand because the allylic position is not very tightly bound to the metal center, makes it easy to be activated to zero-valent palladium at room temperature, insert the C-Cl bond of the aromatic heterocyclic chloride, carry out oxidative addition, and assist the ligand
- the facile nature also greatly facilitates the reductive elimination step in the catalytic cycle, thereby enhancing the overall catalytic activity.
- the phenyl group can generate ⁇ - ⁇ stacking with the aryl substrate, which enhances the electron donating effect of the system, thereby promoting the rate-determining step (oxidation) of the catalytic cycle.
- the large sterically hindered diphenyl skeleton can well wrap the metal active center and enhance the stability of the catalyst; the existence of R 1 , R 1' , R 2 , R 2' , R 3 groups is beneficial to Fine tuning of electrical and steric hindrance of ligands and catalysts. Therefore, compared with the organic phosphine ligands, the carbene ligands and catalysts obtained by the present invention are very stable in air and water, and have low toxicity; they are suitable for industrial production.
- the present invention also provides a preparation method of the above-mentioned large sterically hindered nitrogen heterocyclic carbene palladium complex.
- the large sterically hindered nitrogen heterocyclic carbene palladium complex of the present invention takes the large sterically hindered imidazolium salt substituted by phenyl as the skeleton, and is carried out with the functionalized palladium dimer [Pd-(allyl-R 3 )(uX)] 2 It can be obtained by coordination; more specifically, substituted or unsubstituted diphenylethylenediamine is used as the starting material, and the target product can be obtained through three to four chemical reactions.
- the synthesis method is simple, economical, and suitable for industrial production.
- Described large sterically hindered imidazole salt is a large sterically hindered imidazole X-generation salt, and its structural formula is one of the following:
- R 1 , R 1' , R 2 , R 2' which are the same or different are hydrogen, substituted or unsubstituted C6-20 aryl, substituted or unsubstituted C4-20 heterocyclyl, substituted or unsubstituted C4-20 heterocyclic group, respectively.
- X may be one of Cl, Br, I, CH 3 COO, CF 3 COO, BF 4 , PF 6 , SbF 6 , and OTf.
- the palladium dimer [Pd-(allyl-R 3 )(uX)] 2 has the following structural formula,
- R 3 is hydrogen, substituted or unsubstituted C6-20 aryl, substituted or unsubstituted C4-20 heterocyclyl, substituted or unsubstituted C1-20 alkyl, substituted or unsubstituted C3 Any one of -20 cycloalkyl, substituted amino;
- X may be one of Cl, Br, I, CH 3 COO, CF 3 COO, BF 4 , PF 6 , SbF 6 , and OTf.
- the molar ratio of the phenyl-substituted bulky sterically hindered imidazolium salt to the functionalized palladium dimer is preferably 1:3-3:1, more preferably 2:1-2.4:1.
- the above coordination reaction is carried out under nitrogen protection and in the presence of inorganic bases.
- the molar ratio of the amount of the inorganic base to the phenyl-substituted bulky sterically hindered imidazolium salt is preferably 1:1-4:1.
- the temperature of the above coordination reaction may be 20-120°C, preferably 25-60°C; the reaction time may be 0.5-48h, preferably 2-24h.
- the above-mentioned coordination reaction is preferably carried out in an organic solvent environment, and the organic solvent can be tetrahydrofuran, 2-methyltetrahydrofuran, dioxane, toluene, m-xylene, ethylbenzene, mesitylene, ethylene glycol dimethylbenzene At least one of ether, diethyl ether, methyl tert-butyl ether, anisole, and the like.
- the large sterically hindered imidazole salt of the present invention is a large sterically hindered imidazole X-generation salt, which uses substituted or unsubstituted diphenylethylenediamine (compound 1) as the starting material, and substituted or unsubstituted 2,6- Diisopropyl bromobenzene is subjected to C-N coupling reaction to obtain amino-protected substituted or unsubstituted diphenylethylenediamine derivatives (compound 2), which is then reacted with inorganic X-generation salts to obtain large sterically hindered imidazole X-generation salts ( Compound 3) is then complexed with a palladium dimer to finally obtain an NHC-Pd complex (compound 4) (see the following reaction equation for specific structural examples of each compound).
- the reaction temperature of the C-N coupling reaction is preferably 25-130° C., and the reaction time is preferably 1-96 h.
- the reaction is
- the reaction temperature for the reaction of the compound 2 with the inorganic X-substituted salt is preferably 25-120° C., and the reaction time is preferably 1-48 h.
- the molar ratio of the inorganic X-generation salt to compound 2 is preferably 1:1-4:1, and the reaction can be carried out in an organic solvent.
- the large sterically hindered nitrogen heterocyclic carbene palladium complex of the present invention uses substituted or unsubstituted diphenylethylenediamine as a starting material to obtain the target product, and the substituted or unsubstituted diphenylethylenediamine It can be in different configurations, and the reaction equation for one of the configurations is shown below:
- the large sterically hindered nitrogen heterocyclic carbene palladium complex has significantly improved catalytic activity and stability, and can be applied to efficiently catalyze the C-N coupling reaction, especially the C-N coupling reaction can be efficiently catalyzed at room temperature. Apply it (the compound of the chemical structural formula shown in formula (A) or its enantiomer (B) or racemate (C)) to the C-N coupling reaction of catalyzed inert large aromatic heterocyclic chlorides to achieve the Efficient catalysis at room temperature, and the target product can be obtained in a yield of up to 99%.
- the present invention also provides a method for synthesizing a sony Gibb.
- the three-step synthesis method of the invention not only has few synthesis steps and high yield, but also avoids the palladium-carbon hydrogenation process, and can carry out the reaction at room temperature, thereby being safer and lower in cost, and being suitable for large-scale industrial production.
- the synthetic method uses aryl/aliphatic amine and aryl chloride as reactants, and a palladium catalyzed system to carry out a C-N coupling reaction under the condition of an alkaline solution.
- 3-bromo-2-methylbenzoic acid is subjected to Suzuki coupling reaction with 4-(trifluoromethoxy) phenylboronic acid to obtain biphenyl intermediate 2-methyl-3-(trifluoromethoxy) phenyl)-benzoic acid (I), then condensation reaction with 5-amino-2-chloropyridine to obtain amide intermediate (II), and finally, under the catalysis of palladium catalytic system, with 2,6-dimethyl C-N coupling reaction of morpholine to obtain the final product sononigibb (III). After the reaction, the mixture can be separated by column chromatography.
- the molar ratio of the 3-bromo-2-methylbenzoic acid to 4-(trifluoromethoxy)benzeneboronic acid is preferably 1:1.2-1:2.0.
- the temperature of the Suzuki coupling reaction is preferably 50-150°C.
- the reaction is preferably carried out under the conditions of an alkali and a palladium catalyst, and the palladium catalyst can be palladium acetate, palladium chloride, Pd 2 (dba) 3 , tetrakistriphenylphosphine palladium, etc.; the alkali can be sodium carbonate , potassium carbonate, cesium carbonate, sodium hydroxide, potassium hydroxide, sodium tert-butoxide, potassium tert-butoxide, potassium phosphate, etc.
- the reaction is preferably carried out in a solvent, such as toluene, ethylbenzene, xylene, mesitylene, dioxane, methyl tert-butyl ether, anisole, diethyl ether, ethylene glycol dimethyl ether, tetrahydrofuran , 2-methyltetrahydrofuran, C1-C5 alcohol, dimethyl sulfoxide, dimethylformamide, dimethylacetamide, acetonitrile, water or a combination of two or more mixed solvents thereof.
- a solvent such as toluene, ethylbenzene, xylene, mesitylene, dioxane, methyl tert-butyl ether, anisole, diethyl ether, ethylene glycol dimethyl ether, tetrahydrofuran , 2-methyltetrahydrofuran, C1-C5 alcohol, dimethyl sulfoxide, dimethylformamide, dimethyl
- the temperature of the condensation reaction is preferably 0-80°C; the reaction is preferably carried out in an organic solvent, such as dichloromethane, N,N-dimethylacetamide, N,N-dimethylformamide, Toluene, xylene, ethylbenzene, mesitylene, dioxane, tetrahydrofuran, methyl tert-butyl ether, diethyl ether, ethylene glycol dimethyl ether, C1-C4 alcohol, dimethyl sulfoxide, etc.
- organic solvent such as dichloromethane, N,N-dimethylacetamide, N,N-dimethylformamide, Toluene, xylene, ethylbenzene, mesitylene, dioxane, tetrahydrofuran, methyl tert-butyl ether, diethyl ether, ethylene glycol dimethyl ether, C1-C4 alcohol, dimethyl sul
- the temperature of the CN coupling reaction is preferably 25-130° C., and the reaction time is 1-96 h.
- the reaction is preferably carried out in the presence of a base, such as sodium carbonate, potassium carbonate, cesium carbonate, potassium hydroxide, sodium hydroxide, sodium tert-butoxide, potassium tert-butoxide, potassium phosphate, and the like.
- the reaction is preferably carried out in a solvent, such as dioxane, ethylene glycol dimethyl ether, diethyl ether, methyl tert-butyl ether, anisole, tetrahydrofuran, 2-methyltetrahydrofuran, toluene, m-xylene , ethylbenzene, mesitylene, C1-C5 alcohol, dimethylformamide, dimethylacetamide, DMSO, acetonitrile, water or a combination of two or more mixed solvents.
- a solvent such as dioxane, ethylene glycol dimethyl ether, diethyl ether, methyl tert-butyl ether, anisole, tetrahydrofuran, 2-methyltetrahydrofuran, toluene, m-xylene , ethylbenzene, mesitylene, C1-C5 alcohol, dimethylformamide, dimethylacetamide, DMSO,
- the palladium catalyst system can be a conventional palladium complex catalyst, such as monophosphine ligands (such as biphenyls, binaphthyls, biaryls, indoles, carbazoles, ferrocenes, bridging Side chain biphenyl-based monophosphine ligands, etc.)/palladium (eg PdCl 2 , Pd(OAc) 2 , Pd(dba) 2 , Pd 2 (dba) 3 , Pd(PPh 3 ) 4 , Pd(PPh 3 ) 2 Cl 2 , etc.) catalytic system, etc., preferably the large sterically hindered nitrogen heterocyclic carbene palladium complex (NHC-Pd) - the compound of the chemical structural formula represented by the formula (A) or its enantiomer (B) or Racemate (C). More preferably, when the palladium complex is the large sterically hindered nitrogen heterocyclic carbene
- the Sony Gibb synthesis method provided by the invention has few synthesis steps and high yield, avoids the palladium-carbon hydrogenation process, is safer, has lower cost, and is suitable for large-scale industrial production;
- the large sterically hindered nitrogen heterocyclic carbene of the invention is Palladium complex (NHC-Pd)——the compound of the chemical structural formula shown in formula (A) or its enantiomer (B) or racemate (C) is applied in the above synthesis method, which can realize catalysis at room temperature Efficient C-N coupling of aromatic heterocyclic chlorides to aromatic heterocyclic amines in yields as high as 99%.
- the large sterically hindered nitrogen heterocyclic carbene palladium complex structure of the present invention takes diphenylimidazole as the main ligand skeleton and the functionalized allyl group as the auxiliary ligand.
- the auxiliary ligand As an auxiliary ligand, the allyl position is not very tightly bound to the metal center, so it is easily activated to zero-valent palladium at room temperature, inserting the C-Cl bond of the aromatic heterocyclic chloride, and performing oxidative addition.
- the easy-to-leave nature of auxiliary ligands also greatly facilitates the reductive elimination step in the catalytic cycle, thereby enhancing the overall catalytic activity.
- the phenyl group can generate ⁇ - ⁇ stacking with the aryl substrate, which enhances the electron donating effect of the system, thereby promoting the rate-determining step (oxidation) of the catalytic cycle.
- the large sterically hindered diphenyl skeleton can well wrap the metal active center and enhance the stability of the catalyst. Therefore, compared with the organic phosphine ligands, the carbene ligands and catalysts obtained in the present invention are very stable in air and water, and have low toxicity; they are suitable for industrial production; and they can catalyze relatively inert aromatic heterocyclic chlorides and aromatic heterocyclic compounds at room temperature. Efficient C-N coupling of cyclic amines with yields as high as 99%.
- the large sterically hindered nitrogen heterocyclic carbene palladium complex of the present invention achieves excellent catalytic effect mainly through diphenylimidazole as the main ligand skeleton and functionalized allyl as the auxiliary ligand.
- the substituents R 1 , R 1' , R 2 , R 2' , R 3 introduced into its structure can be used to finely adjust the three-dimensional structure and electrical properties of the ligand and catalyst, but generally do not affect the large sterically hindered nitrogen of the present invention
- Heterocyclic carbene palladium complexes can efficiently catalyze CN coupling at room temperature, and can achieve catalytic effects in yields as high as 99%.
- the R 1 and R 1' are H, and the phenyl group in the structure can generate ⁇ - ⁇ stacking with the aryl substrate, which enhances the electron donating effect of the system, thereby promoting the The rate-determining step (oxidative addition) of the catalytic cycle.
- the R 1 and R 1' are electron-donating groups, such as one of -OMe, cycloalkyl, -Ph, etc.
- the donating groups of R 1 and R 1' The electron group enhances the electron-donating effect of the introduced phenyl group and increases the electrical property of the system; for another example, in one embodiment, the R 1 and R 1' are electron-withdrawing groups, such as -Cl, One of -NO 2 , -CF 3 , etc.
- R 2 and R 2' are H; in another embodiment, R 2 and R 2' are electron donating groups, such as -N(CH 3 ) 2 , cycloalkane In another example, in one embodiment, the R 2 and R 2' are electron withdrawing groups, such as one of -Cl, -NO 2 , -CF 3 , etc.; In an example, the R 2 is H, and R 2 ' is an electron withdrawing or electron donating group, such as one of naphthyl, methoxy, -N(CH 3 ) 2 , -CF 3 , etc.; According to the examples, the substitution of R 2 and R 2' can adjust the electrical properties of the catalyst.
- R 3 is H; in another embodiment, R 3 is -Ph; in another embodiment, R 3 is -CH(CH 3 ) 2 ; according to The examples show that the substitution of R 3 can adjust the electrical properties of the catalyst.
- the catalytic activity of the obtained complex has a certain change, it does not affect its ability to catalyze CN coupling efficiently at room temperature, and can obtain up to 99% of the yield. Catalytic effect; therefore, for those of ordinary skill in the art, without departing from the concept of the present invention, several improvements are made to R 3 , which all belong to the protection scope of the present invention.
- X is one of -Cl, -Br , -I, CH3COO- , CF3COO-, -BF4 , -PF6 , -SbF6 , -OTf.
- Example 6 follows the procedure of Example 1, except replace (1S,2S)-(-)-1,2-diphenylethylenediamine with (1R,2R)-(-)-1,2-diamine Phenylethylenediamine, other raw materials and steps are the same, and finally the azacyclic carbene palladium complex Pd-NHC-1' is prepared.
- racemic 1,2-diphenylethylenediamine as the starting material, the racemic azacyclic carbene palladium complex rac-Pd-NHC-1 can be obtained.
- the configuration of the substituted or unsubstituted diphenylethylenediamine of the starting material is changed, and other raw materials and synthesis methods remain unchanged, and the enantiomeric carbene palladium complex or racemate can be obtained.
- the reaction product is achiral
- the catalytic reaction results obtained by adopting the opposite configuration and enantiomeric optically pure nitrogen-heterocyclic carbene palladium complex and racemic nitrogen-heterocyclic carbene palladium complex are equivalent; and the product is a chiral compound
- different configurations of chiral catalysts will produce corresponding asymmetric catalytic results.
- Pd-NHC-1' and rac-Pd-NHC-1 are selected as the representative of the catalytic effect of the enantiomer and racemate of the carbene palladium catalyst to illustrate the comparison of Pd-NHC-1.
- the route of the present invention has few synthetic steps and high yield, avoids the palladium-carbon hydrogenation process, and can react at room temperature, thereby being safer, having lower cost, and being suitable for large-scale industrial production.
- the dosage is 5 mol%, and the reaction is carried out for 16 hours under the condition of nitrogen at room temperature, and the yield is as high as 90%.
- the total yield of the patent document WO2011009852 is 42.8%
- the total yield of the patent document WO2017163258 is 63.1%
- the total yield of the patent document CN105330658A is 15.1%
- the total yield of the patent document CN109293649A is 58.5%
- the synthesis method of the present invention adopts Pd
- the total yield when catalyzed by -NHC-1 was 74.5%.
- the large sterically hindered nitrogen heterocyclic carbene palladium complex (NHC-Pd) of the present invention is used to realize the efficient C-N coupling of aromatic heterocyclic chloride and aromatic heterocyclic amine for the first time at room temperature, and
- the synthesis steps are few, the yield is high, the palladium-carbon hydrogenation process is avoided, and the reaction can be carried out at room temperature, thereby being safer and lower in cost, and suitable for industrialized large-scale production.
- Example 8 Comparison of catalytic efficiency using the catalysts of Examples 1 to 6 of the present invention and existing catalysts in the art
- the large sterically hindered nitrogen heterocyclic carbene palladium complex (NHC-Pd) of the present invention achieves the effect of efficiently catalyzing C-N coupling, and the catalytic yield can be as high as 93%.
- Embodiment 9 The nitrogen heterocyclic carbene palladium complex of the present invention is applied to the C-N coupling reaction. Compared with the yield obtained by the catalysis of the classical carbene palladium complex, the raw materials used in the reactions (1) to (6) of this embodiment and The solvent is: 1 mmol of aryl (hetero) ring chloride, 1.2 mmol of amine, 1.2 mmol of sodium tert-butoxide, 4 mL of ethylene glycol dimethyl ether.
- Reaction (1) The reaction equation is shown below, and the catalytic efficiency of each catalyst is shown in Table 2 below.
- the large sterically hindered nitrogen heterocyclic carbene palladium complex (NHC-Pd) of the present invention achieves the effect of catalyzing C-N coupling efficiently;
- the lowest catalytic rate is only 10%, and the highest is only 75%.
- the catalytic rate of the complex of the present invention is all close to 90%, and the highest can be as high as 99%.
- Reaction (2) The reaction equation is shown below, and the catalytic efficiency of each catalyst is shown in Table 3 below by taking Pd-NHC-1 as an example.
- Reaction (3) The reaction equation is shown below, and the catalytic efficiency of each catalyst is shown in Table 4 below by taking Pd-NHC-2 as an example.
- Reaction (4) The reaction equation is shown below, and the catalytic efficiency of each catalyst is shown in Table 5 below by taking Pd-NHC-3 as an example.
- Reaction (5) The reaction equation is shown below, and the catalytic efficiency of each catalyst is shown in Table 6 below by taking Pd-NHC-4 as an example.
- Reaction (6) The reaction equation is shown below, and the catalytic efficiency of each catalyst is shown in Table 7 below by taking Pd-NHC-5 as an example.
- Example 10 The azacyclic carbene palladium complex of the present invention is applied to C-N coupling reaction to synthesize compounds with potential pharmacological activity
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
The present invention relates to the technical field of organic synthesis and chemical catalysis. Disclosed are a large steric hinderance palladium-nitrogen-heterocyclic carbene complex, a preparation method for same, applications of same in efficiently catalyzing a C-N coupling reaction in room temperature conditions, and a synthesis method for sonidegib based on same. The structure of the large steric hinderance palladium-nitrogen-heterocyclic carbene complex of the present invention has diphenylimidazole as the main ligand skeleton and a functionalized allyl as an ancillary ligand, with the introduction of the functionalized allyl to serve as an ancillary ligand beside the metal center of a catalyst, provides significantly increased catalytic activity and stability, is applicable in efficiently catalyzing the C-N coupling reaction, specifically, efficiently catalyzing the C-N coupling reaction at room temperature conditions, and attains a yield of up to 99%. Also provided in the present invention is a method for synthesizing in three steps at room temperature with an aryl/aliphatic amine and an aryl chloride as reactants and catalyzed by a palladium catalytic system. The synthesis method of the present invention has few steps and attains a total yield of up to 74.5%.
Description
本发明属于有机合成及化学催化技术领域,特别涉及一种大位阻氮杂环卡宾钯配合物及其制备方法与其在室温条件下高效催化C-N偶联反应的应用,和基于其的索尼吉布的合成方法。The invention belongs to the technical field of organic synthesis and chemical catalysis, and in particular relates to a large sterically hindered nitrogen heterocyclic carbene palladium complex and a preparation method thereof and its application in efficient catalysis of C-N coupling reaction at room temperature, and a sony Gibb based on the same synthetic method.
膦配体和氮杂环卡宾(NHC)配体都是强给电子配体,其钯的配合物能高效催化氧化加成决速步的反应,但是它们在空间立体结构上却有很大差异。1991年,Arduengo首次成功分离出氮杂环自由卡宾;1997年,Tolman等对膦配体空间立体结构进行深入研究,并认为膦配体的空间立体结构呈圆锥形形状,P上大位阻取代基团远离金属活性中心,不能很好地将金属中心包裹起来,缺乏稳定性。而氮杂环卡宾配体恰恰相反,N-芳环上的取代基呈下垂状态,与金属中心距离更近,使催化剂变得更稳定,不易生成钯黑,因此能在空气下,甚至在含水体系中进行高效催化。在随后的二十多年里,氮杂环卡宾金属配合物研究得到了迅速发展,已成为金属有机催化领域的研究热点,尤其是氮杂环卡宾钯配合物催化的C-C、C-O、C-N偶联反应等收获颇丰。Phosphine ligands and nitrogen heterocyclic carbene (NHC) ligands are both strong electron-donating ligands, and their palladium complexes can efficiently catalyze oxidative addition rate-determining reactions, but they have great differences in steric structures. . In 1991, Arduengo successfully isolated the nitrogen heterocyclic free carbene for the first time; in 1997, Tolman et al. conducted in-depth research on the steric structure of phosphine ligands, and believed that the steric structure of phosphine ligands was conical in shape, with large steric substitution on P. The group is far away from the metal active center, cannot wrap the metal center well, and lacks stability. The nitrogen heterocyclic carbene ligand is just the opposite, the substituent on the N-aromatic ring is in a pendant state, and the distance from the metal center is closer, which makes the catalyst more stable, and it is not easy to generate palladium black, so it can be used in air or even in water. efficient catalysis in the system. In the following two decades, the research on N-heterocyclic carbene metal complexes has developed rapidly and has become a research hotspot in the field of metal-organic catalysis, especially the C-C, C-O, C-N coupling catalyzed by N-heterocyclic carbene palladium complexes The response and so on have been fruitful.
过渡金属催化C-N键形成反应对含氮分子的合成影响深远,特别是钯催化芳基卤代物的胺化反应,在工业生产和学术研究中已成为一种非常有价值的工具,被广泛应用于医药、农药、功能材料等功能性化合物的合成与修饰。如下式所示,抗慢性髓细胞性白血病药物Imatinib(伊马替尼)和Nilotinib(尼洛替尼)、抗急性髓细胞性白血病药物Enasidenib(恩西地平)、抗基底细胞癌药物Sonidegib(索尼地吉)、抗帕金森病药Piribedil(吡贝地尔)以及抗炎药Mornifiumate(吗尼氟酯)等。The transition metal-catalyzed C-N bond formation reaction has a profound impact on the synthesis of nitrogen-containing molecules, especially the palladium-catalyzed amination of aryl halides, which has become a very valuable tool in industrial production and academic research, and is widely used in Synthesis and modification of functional compounds such as medicines, pesticides and functional materials. As shown in the following formula, the anti-chronic myeloid leukemia drugs Imatinib (imatinib) and Nilotinib (nilotinib), the anti-acute myeloid leukemia drug Enasidenib (ensidipine), the anti-basal cell carcinoma drug Sonidegib (Sony Digi), the anti-Parkinsonian drug Piribedil (piribedil), and the anti-inflammatory drug Mornifiumate (moniflumate).
迄今为止,二芳胺合成的主要途径是通过钯催化芳基卤代物与芳基胺进行C-N偶联反应来 实现。目前该类反应主要有两大挑战,一个是底物适用类型上的挑战,另一个是反应条件上的挑战。怎样才能使这类反应变得更为温和、更加绿色、底物适用范围更广,是其高效配体及催化剂开发的核心问题。To date, the main route for the synthesis of diarylamines is through the palladium-catalyzed C-N coupling reaction of aryl halides with arylamines. At present, there are two main challenges in this type of reaction, one is the challenge of the type of substrate applicable, and the other is the challenge of the reaction conditions. How to make this type of reaction milder, greener, and applicable to a wider range of substrates is the core issue for the development of efficient ligands and catalysts.
由于芳杂环氯代物是惰性较大的化合物,在室温条件下,过渡金属很难插入C-Cl键进行底物活化,因此,目前绝大部分芳杂环氯代物的C-N偶联是在高温下完成的[(a)Chem.Commun.2011,47,12358.(b)Chem.Sci.2013,4,916.(c)Angew.Chem.2017,129,10705.(d)J.Am.Chem.Soc.2018,140,4721.(e)J.Org.Chem.2018,83,9144.],虽然也有在室温下反应的文献报道[(a)J.Am.Chem.Soc.2006,128,4101.(b)Angew.Chem.2014,126,6600.],但是其催化效率较低。因此,寻找新的催化体系与催化剂,在室温下进行高效的C-N偶联反应,依然是一大热点和难点。Since aromatic heterocyclic chlorides are relatively inert compounds, it is difficult for transition metals to insert C-Cl bonds for substrate activation at room temperature. Therefore, most of the C-N coupling of aromatic heterocyclic chlorides is performed at high temperature. Completed under [(a)Chem.Commun.2011,47,12358.(b)Chem.Sci.2013,4,916.(c)Angew.Chem.2017,129,10705.(d)J.Am.Chem. Soc.2018,140,4721.(e)J.Org.Chem.2018,83,9144.], although there are also literature reports of reaction at room temperature [(a)J.Am.Chem.Soc.2006,128, 4101. (b) Angew. Chem. 2014, 126, 6600.], but its catalytic efficiency is low. Therefore, finding new catalytic systems and catalysts for efficient C-N coupling reactions at room temperature is still a hot and difficult point.
索尼吉布,英文名Sonidegib,是由诺华(Novartis)公司开发并分别于2015年7月24日、2015年8月14日获得美国FDA和EMA批准上市的一种SMO受体拮抗剂,它通过抑制Hedgehog途径,从而阻止或减少癌变的发展。索尼吉布用于治疗无法手术和放疗的局部晚期基底细胞癌患者,或者经手术或放疗后复发的患者。该药是目前仅有的两个治疗基底细胞癌的上市药物之一。索尼吉布化学名称为N-[6-[(2R,6S)-2,6-二甲基-4-吗啉基]-3-吡啶基]-2-甲基-4’-(三氟甲氧基)-[1,1’-联苯]-3-甲酰胺,CAS号为956697-53-3,结构式如下:Sonidegib, English name Sonidegib, is a SMO receptor antagonist developed by Novartis and approved by FDA and EMA on July 24, 2015 and August 14, 2015, respectively. Inhibits the Hedgehog pathway, thereby preventing or reducing the development of cancer. Sonnygib is used to treat patients with locally advanced basal cell carcinoma who are inoperable and inoperable with radiation therapy, or who have recurred after surgery or radiation therapy. The drug is currently one of only two marketed drugs for the treatment of basal cell carcinoma. Sonny Gibb's chemical name is N-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-3-pyridyl]-2-methyl-4'-(trifluoro Methoxy)-[1,1'-biphenyl]-3-carboxamide, the CAS number is 956697-53-3, the structural formula is as follows:
目前,索尼吉布的合成路线主要有以下几种:At present, the synthetic routes of Sony Gibb mainly include the following:
文献(ACS Med.Chem.Lett.2010,1,130-134)和专利文献WO2011009852报道了以2-氯-5-硝基吡啶为起始原料,通过取代、钯碳加氢还原、缩合酰化、Suzuki偶联等四步反应获得索尼吉布,总收率为42.8%。Literature (ACS Med.Chem.Lett.2010,1,130-134) and patent literature WO2011009852 reported that 2-chloro-5-nitropyridine was used as the starting material, through substitution, palladium carbon hydrogenation reduction, condensation acylation, Suzuki Coupling and other four-step reactions were used to obtain Sonny Gibb with a total yield of 42.8%.
专利文献WO2017163258报道了与上述路线一类似的方法,不同之处在于,其先进行Suzuki偶联制得联苯中间体,然后再进行缩合酰化反应制得目标产物索尼吉布,总收率为63.1%。Patent document WO2017163258 reports a method similar to the above-mentioned route 1, the difference is that it first performs Suzuki coupling to obtain biphenyl intermediates, and then performs condensation acylation to obtain the target product Sony Gibb, and the total yield is 63.1%.
专利文献CN105330658A报道了一种新的路线,通过工业原料L-乳酸酯分子间缩合反应制得cis-2R,2’S-双(丙酸酯)醚,该中间体再经过还原反应、磺酰化反应及与N-(6-氨基吡啶-3-基)-2-甲基-4’-(三氟甲氧基)-[1,1’-联苯]-3-甲酰胺的环合反应,制得索尼吉布,总收率为15.1%。Patent document CN105330658A reported a new route, through the intermolecular condensation reaction of industrial raw material L-lactate to obtain cis-2R, 2'S-bis (propionate) ether, the intermediate is then subjected to reduction reaction, sulfonylation Reaction and cyclization with N-(6-aminopyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide , the Sony Gibb was obtained with a total yield of 15.1%.
专利文献CN109293649A报道了另一种新的路线,利用2-氨基-5-硝基吡啶和R-环氧丙烷(或S-环氧丙烷)经环氧开环取代反应、然后经缩合反应制备索尼吉布中间体。该中间体经催化加氢反应还原硝基得到(2S,6R)-2,6-二甲基-4-(5-氨基吡啶-2-基)吗啉,2-甲基-4’-(三氟甲氧基)-[1,1’-联苯]-3-甲酸和酰氯化试剂经酰氯化反应,然后和上述(2S,6R)-2,6-二甲基-4-(5-氨基吡啶-2-基)吗啉经酰胺化反应制备索尼吉布,总收率为58.5%。Patent document CN109293649A reported another new route, utilizing 2-amino-5-nitropyridine and R-epoxy propylene (or S-epoxy propylene) through epoxy ring-opening substitution reaction, and then through condensation reaction to prepare Sony Gibb Intermediates. The intermediate is reduced by catalytic hydrogenation to obtain (2S,6R)-2,6-dimethyl-4-(5-aminopyridin-2-yl)morpholine, 2-methyl-4'-( Trifluoromethoxy)-[1,1'-biphenyl]-3-carboxylic acid and acid chloride reagent were subjected to acid chloride reaction, and then reacted with the above (2S,6R)-2,6-dimethyl-4-(5 -Aminopyridin-2-yl)morpholine was prepared by amidation reaction of Sonnigib with a total yield of 58.5%.
以上四种合成路线,不仅合成路线繁多,而且均需要进行钯碳加氢还原,再加上5-氨基-2- 硝基吡啶价格昂贵,对工业化生产带来了一定的限制。所以,设计和开发新的、简洁经济的合成路线,对于索尼吉布的工业化生产具有重要的现实意义。The above four synthetic routes not only have many synthetic routes, but also require hydrogenation reduction of palladium-carbon, and 5-amino-2-nitropyridine is expensive, which imposes certain restrictions on industrial production. Therefore, the design and development of a new, concise and economical synthesis route has important practical significance for the industrial production of Sony Gibb.
发明内容SUMMARY OF THE INVENTION
为了克服上述现有技术中卡宾钯配合物反应活性较低,室温条件下无法高效催化反应的缺点与不足,本发明的首要目的在于提供一种大位阻氮杂环卡宾钯配合物。In order to overcome the shortcomings and deficiencies of the above-mentioned prior art that the carbene palladium complex has low reactivity and cannot efficiently catalyze the reaction under room temperature conditions, the primary purpose of the present invention is to provide a large sterically hindered nitrogen heterocyclic carbene palladium complex.
本发明的大位阻氮杂环卡宾钯配合物结构以二苯基咪唑为主配体骨架、官能团化烯丙基为辅助配体,具有显著提升的催化活性及稳定性,将其应用于催化芳杂环氯代物的C-N偶联反应,实现了室温条件高效催化芳杂环氯代物的C-N偶联,并能得到高达99%的收率。The large sterically hindered nitrogen heterocyclic carbene palladium complex structure of the present invention takes diphenylimidazole as the main ligand skeleton and the functionalized allyl group as the auxiliary ligand, has significantly improved catalytic activity and stability, and is applied to catalysis The C-N coupling reaction of aromatic heterocyclic chlorides realizes the efficient catalytic C-N coupling of aromatic heterocyclic chlorides at room temperature, and the yield can be as high as 99%.
本发明另一目的在于提供一种上述大位阻氮杂环卡宾钯配合物的制备方法。Another object of the present invention is to provide a preparation method of the above-mentioned large sterically hindered nitrogen heterocyclic carbene palladium complex.
本发明大位阻氮杂环卡宾钯配合物以苯基取代的大位阻咪唑盐为骨架,与官能团化的钯二聚体[Pd-(烯丙基-R
3)(u-X)]
2进行配位得到,更具体地以取代或未取代的二苯基乙二胺为起始原料,经过三到四步化学反应即可得到目标产物,合成方法简单、经济,适合工业化生产。
The large sterically hindered nitrogen heterocyclic carbene palladium complex of the present invention takes the large sterically hindered imidazolium salt substituted by phenyl as the skeleton, and is carried out with the functionalized palladium dimer [Pd-(allyl-R 3 )(uX)] 2 It is obtained by coordination, more specifically, substituted or unsubstituted diphenylethylenediamine is used as the starting material, and the target product can be obtained through three to four chemical reactions. The synthesis method is simple, economical, and suitable for industrial production.
本发明再一目的在于提供上述大位阻氮杂环卡宾钯配合物在高效催化C-N偶联反应中的应用,特别是可在室温条件下高效催化C-N偶联反应。Another object of the present invention is to provide the application of the above-mentioned large sterically hindered nitrogen heterocyclic carbene palladium complex in the efficient catalysis of C-N coupling reaction, especially the C-N coupling reaction can be efficiently catalyzed at room temperature.
本发明再一目的在于提供一种索尼吉布的合成方法。本发明合成方法为三步法合成得到目标产物,不仅合成步骤少、收率高,避免了钯碳加氢过程,而且可在室温条件下进行反应,从而更安全,成本更低,适用于工业化大生产。特别是采用本发明的大位阻氮杂环卡宾钯配合物时可获得室温下反应显著提高的收率。Another object of the present invention is to provide a method for synthesizing a sonny Gibb. The synthesis method of the invention is a three-step synthesis to obtain the target product, which not only has few synthesis steps and high yield, avoids the palladium-carbon hydrogenation process, but also can carry out the reaction at room temperature, thereby being safer and lower in cost, and suitable for industrialization mass production. In particular, when the large sterically hindered nitrogen heterocyclic carbene palladium complex of the present invention is used, a remarkably improved yield of the reaction at room temperature can be obtained.
本发明的目的通过下述方案实现:The object of the present invention is realized through the following scheme:
一种大位阻氮杂环卡宾钯配合物(NHC-Pd配合物),该配合物是具有式(A)所示化学结构式的化合物或它的对映体(B)或消旋体(C):A large sterically hindered nitrogen heterocyclic carbene palladium complex (NHC-Pd complex), the complex is a compound having the chemical structural formula shown in formula (A) or its enantiomer (B) or racemate (C) ):
其中:R
1、R
1’、R
2、R
2’相同或不同的分别为氢、取代或未取代的C6-20的芳基、取代或未取代的C4-20的杂环基、取代或未取代的C1-20的烃氧基、取代或未取代的C1-20的烷基、取代或未取代的C3-20的环烷基、卤素、-Bn、-CF
3、-NO
2、取代氨基中的至少一种;
Wherein: R 1 , R 1' , R 2 , R 2' which are the same or different are hydrogen, substituted or unsubstituted C6-20 aryl, substituted or unsubstituted C4-20 heterocyclyl, substituted or unsubstituted C4-20 heterocyclic group, respectively. Unsubstituted C1-20 hydrocarbyloxy, substituted or unsubstituted C1-20 alkyl, substituted or unsubstituted C3-20 cycloalkyl, halogen, -Bn, -CF 3 , -NO 2 , substituted at least one of amino groups;
R
3为氢、取代或未取代的C6-20的芳基、取代或未取代的C4-20的杂环基、取代或未取代的C1-20的烷基、取代或未取代的C3-20的环烷基、取代氨基中的任意一种;
R 3 is hydrogen, substituted or unsubstituted C6-20 aryl, substituted or unsubstituted C4-20 heterocyclyl, substituted or unsubstituted C1-20 alkyl, substituted or unsubstituted C3-20 Any of the cycloalkyl and substituted amino groups;
X可为-Cl、-Br、-I、CH
3COO-、CF
3COO-、-BF
4、-PF
6、-SbF
6、-OTf中的一种。
X may be one of -Cl, -Br, -I, CH 3 COO-, CF 3 COO-, -BF 4 , -PF 6 , -SbF 6 , -OTf.
上述的取代相同或不同的指基团中的一个或一个以上氢原子可被C6-20的芳基、C4-20的杂 环基、C1-20的烃氧基、C1-20的烷基、C3-20的环烷基、-CF
3、-NO
2、卤素基团等取代。
The same or different substitutions mentioned above mean that one or more hydrogen atoms in the group can be replaced by C6-20 aryl, C4-20 heterocyclic, C1-20 hydrocarbyloxy, C1-20 alkyl, Substitution of C3-20 cycloalkyl, -CF 3 , -NO 2 , halogen group and the like.
本发明的大位阻氮杂环卡宾钯配合物结构以二苯基咪唑为主配体骨架、官能团化烯丙基为辅助配体,通过在催化剂的金属中心旁边引入官能团化烯丙基作为辅助配体,由于烯丙位与金属中心的结合不是很紧密,使其很容易在室温下被活化成零价钯,插入芳杂环氯代物的C-Cl键,进行氧化加成,辅助配体易离去的性质也大大促进了催化循环中的还原消除步骤,从而提升整体催化活性。其次,在咪唑环上引入两个苯基,进行氧化加成时,苯基可以与芳基底物产生π-π堆积,增强了体系的给电子作用,从而促进该催化循环的决速步(氧化加成);大位阻的二苯基骨架可以很好的包裹金属活性中心,增强了催化剂的稳定性;R
1、R
1’、R
2、R
2’、R
3基团的存在有利于配体及催化剂的电性和立体位阻的精细调节。因此,相对于有机膦配体,本发明所得卡宾配体及催化剂在空气和水中非常稳定,而且毒性小;适合工业化生产。
The structure of the large sterically hindered nitrogen heterocyclic carbene palladium complex of the present invention takes diphenylimidazole as the main ligand skeleton and the functionalized allyl group as the auxiliary ligand. By introducing the functionalized allyl group next to the metal center of the catalyst as the auxiliary ligand The ligand, because the allylic position is not very tightly bound to the metal center, makes it easy to be activated to zero-valent palladium at room temperature, insert the C-Cl bond of the aromatic heterocyclic chloride, carry out oxidative addition, and assist the ligand The facile nature also greatly facilitates the reductive elimination step in the catalytic cycle, thereby enhancing the overall catalytic activity. Secondly, two phenyl groups are introduced on the imidazole ring, and during oxidative addition, the phenyl group can generate π-π stacking with the aryl substrate, which enhances the electron donating effect of the system, thereby promoting the rate-determining step (oxidation) of the catalytic cycle. addition); the large sterically hindered diphenyl skeleton can well wrap the metal active center and enhance the stability of the catalyst; the existence of R 1 , R 1' , R 2 , R 2' , R 3 groups is beneficial to Fine tuning of electrical and steric hindrance of ligands and catalysts. Therefore, compared with the organic phosphine ligands, the carbene ligands and catalysts obtained by the present invention are very stable in air and water, and have low toxicity; they are suitable for industrial production.
本发明还提供一种上述大位阻氮杂环卡宾钯配合物的制备方法。本发明大位阻氮杂环卡宾钯配合物以苯基取代的大位阻咪唑盐为骨架,与官能团化的钯二聚体[Pd-(烯丙基-R
3)(u-X)]
2进行配位得到;更具体地以取代或未取代的二苯基乙二胺为起始原料,经过三到四步化学反应即可得到目标产物,合成方法简单、经济,适合工业化生产。
The present invention also provides a preparation method of the above-mentioned large sterically hindered nitrogen heterocyclic carbene palladium complex. The large sterically hindered nitrogen heterocyclic carbene palladium complex of the present invention takes the large sterically hindered imidazolium salt substituted by phenyl as the skeleton, and is carried out with the functionalized palladium dimer [Pd-(allyl-R 3 )(uX)] 2 It can be obtained by coordination; more specifically, substituted or unsubstituted diphenylethylenediamine is used as the starting material, and the target product can be obtained through three to four chemical reactions. The synthesis method is simple, economical, and suitable for industrial production.
所述的大位阻咪唑盐为大位阻咪唑X代盐,其结构式如下之一:Described large sterically hindered imidazole salt is a large sterically hindered imidazole X-generation salt, and its structural formula is one of the following:
其中:R
1、R
1’、R
2、R
2’相同或不同的分别为氢、取代或未取代的C6-20的芳基、取代或未取代的C4-20的杂环基、取代或未取代的C1-20的烃氧基、取代或未取代的C1-20的烷基、取代或未取代的C3-20的环烷基、卤素、-Bn、-CF
3、-NO
2、取代氨基中的至少一种;
Wherein: R 1 , R 1' , R 2 , R 2' which are the same or different are hydrogen, substituted or unsubstituted C6-20 aryl, substituted or unsubstituted C4-20 heterocyclyl, substituted or unsubstituted C4-20 heterocyclic group, respectively. Unsubstituted C1-20 hydrocarbyloxy, substituted or unsubstituted C1-20 alkyl, substituted or unsubstituted C3-20 cycloalkyl, halogen, -Bn, -CF 3 , -NO 2 , substituted at least one of amino groups;
X可为Cl、Br、I、CH
3COO、CF
3COO、BF
4、PF
6、SbF
6、OTf中的一种。
X may be one of Cl, Br, I, CH 3 COO, CF 3 COO, BF 4 , PF 6 , SbF 6 , and OTf.
所述的钯二聚体[Pd-(烯丙基-R
3)(u-X)]
2,其结构式如下所示,
The palladium dimer [Pd-(allyl-R 3 )(uX)] 2 has the following structural formula,
其中,R
3为氢、取代或未取代的C6-20的芳基、取代或未取代的C4-20的杂环基、取代或未取代的C1-20的烷基、取代或未取代的C3-20的环烷基、取代氨基中的任意一种;
Wherein, R 3 is hydrogen, substituted or unsubstituted C6-20 aryl, substituted or unsubstituted C4-20 heterocyclyl, substituted or unsubstituted C1-20 alkyl, substituted or unsubstituted C3 Any one of -20 cycloalkyl, substituted amino;
X可为Cl、Br、I、CH
3COO、CF
3COO、BF
4、PF
6、SbF
6、OTf中的一种。
X may be one of Cl, Br, I, CH 3 COO, CF 3 COO, BF 4 , PF 6 , SbF 6 , and OTf.
所述的苯基取代的大位阻咪唑盐与官能团化的钯二聚体的摩尔比优选为1:3-3:1,更优选为2:1-2.4:1。The molar ratio of the phenyl-substituted bulky sterically hindered imidazolium salt to the functionalized palladium dimer is preferably 1:3-3:1, more preferably 2:1-2.4:1.
上述配位反应在氮气保护、无机碱存在下进行。The above coordination reaction is carried out under nitrogen protection and in the presence of inorganic bases.
所述无机碱的用量与苯基取代的大位阻咪唑盐的摩尔比优选为1:1-4:1。The molar ratio of the amount of the inorganic base to the phenyl-substituted bulky sterically hindered imidazolium salt is preferably 1:1-4:1.
上述配位反应的温度可为20-120℃,优选为25-60℃;反应的时间可为0.5-48h,优选为2-24h。The temperature of the above coordination reaction may be 20-120°C, preferably 25-60°C; the reaction time may be 0.5-48h, preferably 2-24h.
上述配位反应优选在有机溶剂环境中进行,所述的有机溶剂可为四氢呋喃、2-甲基四氢呋喃、二氧六环、甲苯、间二甲苯、乙苯、均三甲苯、乙二醇二甲醚、乙醚、甲基叔丁基醚、苯甲醚等中的至少一种。The above-mentioned coordination reaction is preferably carried out in an organic solvent environment, and the organic solvent can be tetrahydrofuran, 2-methyltetrahydrofuran, dioxane, toluene, m-xylene, ethylbenzene, mesitylene, ethylene glycol dimethylbenzene At least one of ether, diethyl ether, methyl tert-butyl ether, anisole, and the like.
本发明所述的大位阻咪唑盐为大位阻咪唑X代盐,以取代或未取代的二苯基乙二胺(化合物1)为起始原料,与取代或未取代的2,6-二异丙基溴苯经C-N偶联反应,得到氨基保护的取代或未取代的二苯基乙二胺衍生物(化合物2),再与无机X代盐反应得到大位阻咪唑X代盐(化合物3),接着与钯二聚体络合,最终获得NHC-Pd配合物(化合物4)(各化合物具体结构示例见下述反应方程式)。所述C-N偶联反应的反应温度优选为25-130℃,反应时间优选为1-96h。反应优选在无机碱、钯催化剂及有机溶剂环境下进行。The large sterically hindered imidazole salt of the present invention is a large sterically hindered imidazole X-generation salt, which uses substituted or unsubstituted diphenylethylenediamine (compound 1) as the starting material, and substituted or unsubstituted 2,6- Diisopropyl bromobenzene is subjected to C-N coupling reaction to obtain amino-protected substituted or unsubstituted diphenylethylenediamine derivatives (compound 2), which is then reacted with inorganic X-generation salts to obtain large sterically hindered imidazole X-generation salts ( Compound 3) is then complexed with a palladium dimer to finally obtain an NHC-Pd complex (compound 4) (see the following reaction equation for specific structural examples of each compound). The reaction temperature of the C-N coupling reaction is preferably 25-130° C., and the reaction time is preferably 1-96 h. The reaction is preferably carried out in the environment of an inorganic base, a palladium catalyst and an organic solvent.
所述化合物2与无机X代盐反应的反应温度优选为25-120℃,反应时间优选为1-48h。所述无机X代盐与化合物2的摩尔比优选为1:1-4:1,反应可在有机溶剂中进行。The reaction temperature for the reaction of the compound 2 with the inorganic X-substituted salt is preferably 25-120° C., and the reaction time is preferably 1-48 h. The molar ratio of the inorganic X-generation salt to compound 2 is preferably 1:1-4:1, and the reaction can be carried out in an organic solvent.
更具体的,本发明的大位阻氮杂环卡宾钯配合物以取代或未取代的二苯基乙二胺为起始原料得到目标产物,所述取代或未取代的二苯基乙二胺可为不同构型,其中一种构型的反应方程式如下所示:More specifically, the large sterically hindered nitrogen heterocyclic carbene palladium complex of the present invention uses substituted or unsubstituted diphenylethylenediamine as a starting material to obtain the target product, and the substituted or unsubstituted diphenylethylenediamine It can be in different configurations, and the reaction equation for one of the configurations is shown below:
路线一route one
路线二route two
参照上述反应路线,改变取代或未取代的二苯基乙二胺(化合物1)的构型,可制得上述化合物4的对映体和消旋体(即式(B)和式(C)所示化合物)。Referring to the above reaction scheme, by changing the configuration of substituted or unsubstituted diphenylethylenediamine (compound 1), the enantiomer and racemate of the above compound 4 (ie formula (B) and formula (C) can be prepared compounds shown).
本发明的大位阻氮杂环卡宾钯配合物具有显著提升的催化活性及稳定性,可应用于高效催化C-N偶联反应,特别是可在室温条件下高效催化C-N偶联反应。将其(式(A)所示化学结构式的化合物或它的对映体(B)或消旋体(C))应用于催化惰性大的芳杂环氯代物的C-N偶联反应,实现了在室温条件下的高效催化,并能得到高达99%收率的目标产物。The large sterically hindered nitrogen heterocyclic carbene palladium complex has significantly improved catalytic activity and stability, and can be applied to efficiently catalyze the C-N coupling reaction, especially the C-N coupling reaction can be efficiently catalyzed at room temperature. Apply it (the compound of the chemical structural formula shown in formula (A) or its enantiomer (B) or racemate (C)) to the C-N coupling reaction of catalyzed inert large aromatic heterocyclic chlorides to achieve the Efficient catalysis at room temperature, and the target product can be obtained in a yield of up to 99%.
本发明还提供一种索尼吉布的合成方法。本发明三步法合成方法不仅合成步骤少、收率高,避免了钯碳加氢过程,而且可在室温条件下进行反应,从而更安全,成本更低,适用于工业化大生产。The present invention also provides a method for synthesizing a sony Gibb. The three-step synthesis method of the invention not only has few synthesis steps and high yield, but also avoids the palladium-carbon hydrogenation process, and can carry out the reaction at room temperature, thereby being safer and lower in cost, and being suitable for large-scale industrial production.
所述合成方法以芳基/脂肪胺、芳基氯代物为反应物,钯催化体系,在碱性溶液条件下进行C-N偶联反应。The synthetic method uses aryl/aliphatic amine and aryl chloride as reactants, and a palladium catalyzed system to carry out a C-N coupling reaction under the condition of an alkaline solution.
更具体为,3-溴-2-甲基苯甲酸与4-(三氟甲氧基)苯硼酸进行Suzuki偶联反应,制得联苯中间体2-甲基-3-(三氟甲氧基苯基)-苯甲酸(I),然后与5-氨基-2-氯吡啶进行缩合反应,制得酰胺中间体(II),最后在钯催化体系的催化下,与2,6-二甲基吗啉进行C-N偶联反应,制得最终产物索尼吉布(III)。反应后混合物可经柱层析分离。More specifically, 3-bromo-2-methylbenzoic acid is subjected to Suzuki coupling reaction with 4-(trifluoromethoxy) phenylboronic acid to obtain biphenyl intermediate 2-methyl-3-(trifluoromethoxy) phenyl)-benzoic acid (I), then condensation reaction with 5-amino-2-chloropyridine to obtain amide intermediate (II), and finally, under the catalysis of palladium catalytic system, with 2,6-dimethyl C-N coupling reaction of morpholine to obtain the final product sononigibb (III). After the reaction, the mixture can be separated by column chromatography.
反应方程式如下所示:The reaction equation is as follows:
所述3-溴-2-甲基苯甲酸与4-(三氟甲氧基)苯硼酸的摩尔比优选为1:1.2-1:2.0。所述Suzuki偶联反应的温度优选为50-150℃。所述反应优选在碱、钯催化剂条件下进行,所述的钯催化剂可为醋酸钯、氯化钯、Pd
2(dba)
3、四三苯基膦钯等;所述的碱可为碳酸钠、碳酸钾、碳酸铯、氢氧化钠、氢氧化钾、叔丁醇钠、叔丁醇钾、磷酸钾等。所述反应优选在溶剂中进行,如可为甲苯、乙苯、二甲苯、均三甲苯、二氧六环、甲基叔丁基醚、苯甲醚、乙醚、乙二醇二甲醚、四氢呋喃、2-甲基四氢呋喃、C1-C5醇、二甲亚砜、二甲基甲酰胺、二甲基乙酰胺、乙腈、水或其两种或两种以上的混合溶剂的组合。
The molar ratio of the 3-bromo-2-methylbenzoic acid to 4-(trifluoromethoxy)benzeneboronic acid is preferably 1:1.2-1:2.0. The temperature of the Suzuki coupling reaction is preferably 50-150°C. The reaction is preferably carried out under the conditions of an alkali and a palladium catalyst, and the palladium catalyst can be palladium acetate, palladium chloride, Pd 2 (dba) 3 , tetrakistriphenylphosphine palladium, etc.; the alkali can be sodium carbonate , potassium carbonate, cesium carbonate, sodium hydroxide, potassium hydroxide, sodium tert-butoxide, potassium tert-butoxide, potassium phosphate, etc. The reaction is preferably carried out in a solvent, such as toluene, ethylbenzene, xylene, mesitylene, dioxane, methyl tert-butyl ether, anisole, diethyl ether, ethylene glycol dimethyl ether, tetrahydrofuran , 2-methyltetrahydrofuran, C1-C5 alcohol, dimethyl sulfoxide, dimethylformamide, dimethylacetamide, acetonitrile, water or a combination of two or more mixed solvents thereof.
所述缩合反应的温度优选为0-80℃;所述反应优选在有机溶剂中进行,如可为二氯甲烷、N,N-二甲基乙酰胺、N,N-二甲基甲酰胺、甲苯、二甲苯、乙苯、均三甲苯、二氧六环、四氢呋喃、甲基叔丁基醚、乙醚、乙二醇二甲醚、C1-C4醇、二甲亚砜等。The temperature of the condensation reaction is preferably 0-80°C; the reaction is preferably carried out in an organic solvent, such as dichloromethane, N,N-dimethylacetamide, N,N-dimethylformamide, Toluene, xylene, ethylbenzene, mesitylene, dioxane, tetrahydrofuran, methyl tert-butyl ether, diethyl ether, ethylene glycol dimethyl ether, C1-C4 alcohol, dimethyl sulfoxide, etc.
所述C-N偶联反应的温度优选为25-130℃,反应时间为1-96h。所述反应优选在碱存在下进行,如可为碳酸钠、碳酸钾、碳酸铯、氢氧化钾、氢氧化钠、叔丁醇钠、叔丁醇钾、磷酸钾等。所述反应优选在溶剂中进行,如可为二氧六环、乙二醇二甲醚、乙醚、甲基叔丁基醚、苯甲醚、四氢呋喃、2-甲基四氢呋喃、甲苯、间二甲苯、乙苯、均三甲苯、C1-C5醇、二甲基甲酰胺、二甲基乙酰胺、DMSO、乙腈、水或其两种或两种以上的混合溶剂的组合。所述的钯催化体系可为常规的钯配合物催化剂,如单膦配体(例如联苯类、联萘类、联芳类、吲哚类、咔唑类、二茂铁类、含有桥连侧链联苯类单膦配体等)/钯(例如PdCl
2、Pd(OAc)
2、Pd(dba)
2、Pd
2(dba)
3、Pd(PPh
3)
4、Pd(PPh
3)
2Cl
2等)催化体系等,优选为本发明的大位阻氮杂环卡宾钯配合物(NHC-Pd)——式(A)所示化学结构式的化合物或它的对映体(B)或消旋体(C)。更优选的,所述的钯配合物为本发明的大位阻氮杂环卡宾钯配合物(NHC-Pd)时,所述的C-N偶联反应的温度可为25-40℃。
The temperature of the CN coupling reaction is preferably 25-130° C., and the reaction time is 1-96 h. The reaction is preferably carried out in the presence of a base, such as sodium carbonate, potassium carbonate, cesium carbonate, potassium hydroxide, sodium hydroxide, sodium tert-butoxide, potassium tert-butoxide, potassium phosphate, and the like. The reaction is preferably carried out in a solvent, such as dioxane, ethylene glycol dimethyl ether, diethyl ether, methyl tert-butyl ether, anisole, tetrahydrofuran, 2-methyltetrahydrofuran, toluene, m-xylene , ethylbenzene, mesitylene, C1-C5 alcohol, dimethylformamide, dimethylacetamide, DMSO, acetonitrile, water or a combination of two or more mixed solvents. The palladium catalyst system can be a conventional palladium complex catalyst, such as monophosphine ligands (such as biphenyls, binaphthyls, biaryls, indoles, carbazoles, ferrocenes, bridging Side chain biphenyl-based monophosphine ligands, etc.)/palladium (eg PdCl 2 , Pd(OAc) 2 , Pd(dba) 2 , Pd 2 (dba) 3 , Pd(PPh 3 ) 4 , Pd(PPh 3 ) 2 Cl 2 , etc.) catalytic system, etc., preferably the large sterically hindered nitrogen heterocyclic carbene palladium complex (NHC-Pd) - the compound of the chemical structural formula represented by the formula (A) or its enantiomer (B) or Racemate (C). More preferably, when the palladium complex is the large sterically hindered nitrogen heterocyclic carbene palladium complex (NHC-Pd) of the present invention, the temperature of the CN coupling reaction may be 25-40°C.
本发明提供的索尼吉布合成方法合成步骤少、收率高,避免了钯碳加氢过程,从而更安全,成本更低,适用于工业化大生产;将本发明的大位阻氮杂环卡宾钯配合物(NHC-Pd)——式(A)所示化学结构式的化合物或它的对映体(B)或消旋体(C)应用于上述合成方法中,可实现在室温条件下催化芳杂环氯代物与芳杂环胺的高效C-N偶联,并能得到高达99%的收率。The Sony Gibb synthesis method provided by the invention has few synthesis steps and high yield, avoids the palladium-carbon hydrogenation process, is safer, has lower cost, and is suitable for large-scale industrial production; the large sterically hindered nitrogen heterocyclic carbene of the invention is Palladium complex (NHC-Pd)——the compound of the chemical structural formula shown in formula (A) or its enantiomer (B) or racemate (C) is applied in the above synthesis method, which can realize catalysis at room temperature Efficient C-N coupling of aromatic heterocyclic chlorides to aromatic heterocyclic amines in yields as high as 99%.
下面结合实施例对本发明作进一步详细的描述,但本发明的实施方式不限于此。下列实施例中涉及的物料若无特殊说明均可从商业渠道获得。所述方法若无特别说明均为常规方法。The present invention will be described in further detail below with reference to the examples, but the embodiments of the present invention are not limited thereto. The materials involved in the following examples can be obtained from commercial channels unless otherwise specified. The methods are conventional methods unless otherwise specified.
一实施方式,一种大位阻氮杂环卡宾钯配合物(NHC-Pd配合物),结构式如下所示:One embodiment, a large sterically hindered nitrogen heterocyclic carbene palladium complex (NHC-Pd complex), the structural formula is as follows:
另一实施方式,一种大位阻氮杂环卡宾钯配合物(NHC-Pd配合物),结构式如下所示:Another embodiment, a large sterically hindered nitrogen heterocyclic carbene palladium complex (NHC-Pd complex), the structural formula is as follows:
再一实施方式,一种大位阻氮杂环卡宾钯配合物(NHC-Pd配合物),结构式如下所示:Yet another embodiment, a large sterically hindered nitrogen heterocyclic carbene palladium complex (NHC-Pd complex), the structural formula is as follows:
需要说明的是,本发明的大位阻氮杂环卡宾钯配合物结构以二苯基咪唑为主配体骨架、官能团化烯丙基为辅助配体,通过在催化剂的金属中心旁边引入官能团化烯丙基作为辅助配体,由于烯丙位与金属中心的结合不是很紧密,使其很容易在室温下被活化成零价钯,插入芳杂环氯代物的C-Cl键,进行氧化加成,辅助配体易离去的性质也大大促进了催化循环中的还原消除步骤,从而提升整体催化活性。其次,在咪唑环上引入两个苯基,进行氧化加成时,苯基可以与芳基底物产生π-π堆积,增强了体系的给电子作用,从而促进该催化循环的决速步(氧化加成);大位阻的二苯基骨架可以很好的包裹金属活性中心,增强了催化剂的稳定性。因此,相对于有机膦配体,本发明所得卡宾配体及催化剂在空气和水中非常稳定,而且毒性小;适合工业化生产;且可在室温条件下催化比较惰性的芳杂环氯代物与芳杂环胺的高效C-N偶联,并能得到高达99%的收率。It should be noted that the large sterically hindered nitrogen heterocyclic carbene palladium complex structure of the present invention takes diphenylimidazole as the main ligand skeleton and the functionalized allyl group as the auxiliary ligand. As an auxiliary ligand, the allyl position is not very tightly bound to the metal center, so it is easily activated to zero-valent palladium at room temperature, inserting the C-Cl bond of the aromatic heterocyclic chloride, and performing oxidative addition. The easy-to-leave nature of auxiliary ligands also greatly facilitates the reductive elimination step in the catalytic cycle, thereby enhancing the overall catalytic activity. Secondly, two phenyl groups are introduced on the imidazole ring, and during oxidative addition, the phenyl group can generate π-π stacking with the aryl substrate, which enhances the electron donating effect of the system, thereby promoting the rate-determining step (oxidation) of the catalytic cycle. addition); the large sterically hindered diphenyl skeleton can well wrap the metal active center and enhance the stability of the catalyst. Therefore, compared with the organic phosphine ligands, the carbene ligands and catalysts obtained in the present invention are very stable in air and water, and have low toxicity; they are suitable for industrial production; and they can catalyze relatively inert aromatic heterocyclic chlorides and aromatic heterocyclic compounds at room temperature. Efficient C-N coupling of cyclic amines with yields as high as 99%.
进一步的,本发明的大位阻氮杂环卡宾钯配合物主要通过二苯基咪唑为主配体骨架、官能团化烯丙基为辅助配体实现优异的催化效果。其结构中引入的取代基R
1、R
1’、R
2、R
2’、R
3可用于精细调节配体及催化剂的立体结构和电性,但是总体上不影响本发明的大位阻氮杂环卡宾钯配合物可在室温下高效催化C-N偶联,并能得到高达99%的收率的催化效果。
Further, the large sterically hindered nitrogen heterocyclic carbene palladium complex of the present invention achieves excellent catalytic effect mainly through diphenylimidazole as the main ligand skeleton and functionalized allyl as the auxiliary ligand. The substituents R 1 , R 1' , R 2 , R 2' , R 3 introduced into its structure can be used to finely adjust the three-dimensional structure and electrical properties of the ligand and catalyst, but generally do not affect the large sterically hindered nitrogen of the present invention Heterocyclic carbene palladium complexes can efficiently catalyze CN coupling at room temperature, and can achieve catalytic effects in yields as high as 99%.
如,在其中一个实施例中,所述的R
1和R
1’为H,此时结构中的苯基可以与芳基底物产生 π-π堆积,增强了体系的给电子作用,从而促进该催化循环的决速步(氧化加成)。在一个实施例中,所述的R
1和R
1’为供电子基团,如可为-OMe、环烷基、-Ph等中的一种,此时,R
1和R
1’的供电子基团使引入的苯基的给电子作用增强,使体系电性增大;又如在一个实施例中,所述的R
1和R
1’为吸电子基团,如可为-Cl、-NO
2、-CF
3等中的一种,此时,R
1和R
1’的吸电子基团使引入的苯基的给电子作用减弱,使体系电性变小,所得配合物的催化活性虽然有一定变化,但是不影响其可在室温下高效催化C-N偶联,并能得到高达99%的收率的催化效果;因此对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,对R
1和R
1’进行若干改进,这些都属于本发明的保护范围。
For example, in one of the embodiments, the R 1 and R 1' are H, and the phenyl group in the structure can generate π-π stacking with the aryl substrate, which enhances the electron donating effect of the system, thereby promoting the The rate-determining step (oxidative addition) of the catalytic cycle. In one embodiment, the R 1 and R 1' are electron-donating groups, such as one of -OMe, cycloalkyl, -Ph, etc. In this case, the donating groups of R 1 and R 1' The electron group enhances the electron-donating effect of the introduced phenyl group and increases the electrical property of the system; for another example, in one embodiment, the R 1 and R 1' are electron-withdrawing groups, such as -Cl, One of -NO 2 , -CF 3 , etc. At this time, the electron-withdrawing groups of R 1 and R 1' weaken the electron-donating effect of the introduced phenyl group, so that the electrical properties of the system become smaller, and the catalysis of the obtained complexes Although there is a certain change in the activity, it does not affect the catalytic effect of high-efficiency catalysis of CN coupling at room temperature and can obtain a yield of up to 99%; therefore, for those of ordinary skill in the art, without departing from the concept of the present invention. Under the premise of the present invention, several improvements are made to R 1 and R 1' , which all belong to the protection scope of the present invention.
又,在其中一个实施例中,R
2和R
2’为H;在另一个实施例中,R
2和R
2’为供电子基团,如可为-N(CH
3)
2、环烷基等;又如在一个实施例中,所述的R
2和R
2’为吸电子基团,如可为-Cl、-NO
2、-CF
3等中的一种;又如在一个实施例中,所述的R
2为H,R
2’为吸电子或供电子基团,如可为萘基、甲氧基、-N(CH
3)
2、-CF
3等中的一种;根据实施例可知,R
2和R
2’的取代可调节催化剂的电性,所得配合物的催化活性虽然有一定变化,但是不影响其可在室温下高效催化C-N偶联,并能得到高达99%的收率的催化效果;因此对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,对R
2和R
2’进行若干改进,这些都属于本发明的保护范围。
Also, in one embodiment, R 2 and R 2' are H; in another embodiment, R 2 and R 2' are electron donating groups, such as -N(CH 3 ) 2 , cycloalkane In another example, in one embodiment, the R 2 and R 2' are electron withdrawing groups, such as one of -Cl, -NO 2 , -CF 3 , etc.; In an example, the R 2 is H, and R 2 ' is an electron withdrawing or electron donating group, such as one of naphthyl, methoxy, -N(CH 3 ) 2 , -CF 3 , etc.; According to the examples, the substitution of R 2 and R 2' can adjust the electrical properties of the catalyst. Although the catalytic activity of the obtained complex has a certain change, it does not affect its efficient catalytic CN coupling at room temperature, and can obtain up to 99 Therefore, for those of ordinary skill in the art, under the premise of not departing from the concept of the present invention, several improvements are made to R 2 and R 2' , which all belong to the protection scope of the present invention.
又,在其中一个实施例中,R
3为H;在另一个实施例中,R
3为-Ph;又如在一个实施例中,所述的R
3为-CH(CH
3)
2;根据实施例可知,R
3的取代可调节催化剂的电性,所得配合物的催化活性虽然有一定变化,但是不影响其可在室温下高效催化C-N偶联,并能得到高达99%的收率的催化效果;因此对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,对R
3进行若干改进,这些都属于本发明的保护范围。
Also, in one embodiment, R 3 is H; in another embodiment, R 3 is -Ph; in another embodiment, R 3 is -CH(CH 3 ) 2 ; according to The examples show that the substitution of R 3 can adjust the electrical properties of the catalyst. Although the catalytic activity of the obtained complex has a certain change, it does not affect its ability to catalyze CN coupling efficiently at room temperature, and can obtain up to 99% of the yield. Catalytic effect; therefore, for those of ordinary skill in the art, without departing from the concept of the present invention, several improvements are made to R 3 , which all belong to the protection scope of the present invention.
在其中一个实施例中,X为-Cl、-Br、-I、CH
3COO-、CF
3COO-、-BF
4、-PF
6、-SbF
6、-OTf中的一种。
In one embodiment, X is one of -Cl, -Br , -I, CH3COO- , CF3COO-, -BF4 , -PF6 , -SbF6 , -OTf.
下面是具体实施例部分。The following is the specific example section.
实施例1:氮杂环卡宾钯配合物Pd-NHC-1的合成Example 1: Synthesis of nitrogen heterocyclic carbene palladium complex Pd-NHC-1
(1)二胺化合物2a的合成:(1) Synthesis of diamine compound 2a:
将5mmol的(1S,2S)-(-)-1,2-二苯基乙二胺、18mmol的tBuONa、15mmol的2,6-二异丙基溴苯、1.5mmol的IPrMe·HCl、0.5mmol的Pd(dba)
2混合,加入20mL无水甲苯,氮气氛围下110℃反应24h。反应完毕,加水稀释,乙酸乙酯萃取3次,无水Na
2SO
4干燥。减压旋干溶剂,粗产品经硅胶柱层析后得到白色固体(洗脱剂:石油醚/二氯甲烷=10:1)。产物产量:1.70g,产率:65%。
1H NMR(400MHz,CDCl
3)δ7.06-6.99(m,16H),4.58(s,2H),4.24(s,2H),3.29(dt,J=13.1,6.4Hz,4H),1.23(d,J=6.6Hz,12H),0.91(d,J=6.5Hz,12H).
13C NMR(101MHz,CDCl
3)δ143.1,141.3,140.2,128.4,127.8,127.0,123.7,123.4,69.1,27.7,24.2,23.6。
5mmol of (1S,2S)-(-)-1,2-diphenylethylenediamine, 18mmol of tBuONa, 15mmol of 2,6-diisopropylbromobenzene, 1.5mmol of IPrMe·HCl, 0.5mmol of Pd(dba) 2 was mixed, 20 mL of anhydrous toluene was added, and the reaction was carried out at 110 °C for 24 h under nitrogen atmosphere. The reaction was completed, diluted with water, extracted with ethyl acetate three times, and dried over anhydrous Na 2 SO 4 . The solvent was spin-dried under reduced pressure, and the crude product was subjected to silica gel column chromatography to obtain a white solid (eluent: petroleum ether/dichloromethane=10:1). Product yield: 1.70 g, yield: 65%. 1 H NMR (400 MHz, CDCl 3 ) δ 7.06-6.99 (m, 16H), 4.58 (s, 2H), 4.24 (s, 2H), 3.29 (dt, J=13.1, 6.4 Hz, 4H), 1.23 ( d, J=6.6Hz, 12H), 0.91 (d, J=6.5Hz, 12H). 13 C NMR (101MHz, CDCl 3 ) δ 143.1, 141.3, 140.2, 128.4, 127.8, 127.0, 123.7, 123.4, 69.1, 27.7 , 24.2, 23.6.
(2)氮杂环卡宾X代盐3a-3c的合成:(2) Synthesis of azacyclic carbene X-generation salts 3a-3c:
1.氮杂环卡宾四氟硼酸盐3a的合成1. Synthesis of azacyclic carbene tetrafluoroborate 3a
将2mmol二胺化合物2a、2.1mmol四氟硼酸铵、2滴甲酸、5mL原甲酸甲酯,5mL四氢呋喃,氮气氛围下120℃反应24h。反应完毕,减压旋干溶剂,经硅胶柱层析后得到白色固体(洗脱剂:先用石油醚/二氯甲烷=2:1,再用纯乙酸乙酯)。产物产量:1.1g,产率:90%。
1H NMR(400MHz,CDCl
3)δ8.94(s,1H),7.47–7.31(m,10H),7.26–7.25(m,4H),7.04(d,J=7.6Hz,2H),5.89(s,2H),3.22(dt,J=13.5,6.7Hz,2H),2.64(dt,J=13.4,6.7Hz,2H),1.72(d,J=6.8Hz,6H),1.46(d,J=6.7Hz,6H),1.12(d,J=6.8Hz,6H),0.43(d,J=6.7Hz,6H).
13C NMR(101MHz,CDCl
3)δ158.8,147.3,145.6,131.6,130.9,129.9,129.7,128.9,127.7,125.0,124.8,74.2,29.9,29.7,25.2,24.8,24.7,22.0。
2 mmol of diamine compound 2a, 2.1 mmol of ammonium tetrafluoroborate, 2 drops of formic acid, 5 mL of methyl orthoformate, and 5 mL of tetrahydrofuran were reacted at 120° C. for 24 h under nitrogen atmosphere. After the reaction was completed, the solvent was spin-dried under reduced pressure, and a white solid was obtained after silica gel column chromatography (eluent: petroleum ether/dichloromethane=2:1, then pure ethyl acetate). Product yield: 1.1 g, yield: 90%. 1 H NMR (400MHz, CDCl 3 ) δ 8.94 (s, 1H), 7.47-7.31 (m, 10H), 7.26-7.25 (m, 4H), 7.04 (d, J=7.6Hz, 2H), 5.89 ( s,2H),3.22(dt,J=13.5,6.7Hz,2H),2.64(dt,J=13.4,6.7Hz,2H),1.72(d,J=6.8Hz,6H),1.46(d,J =6.7Hz, 6H), 1.12(d, J=6.8Hz, 6H), 0.43(d, J=6.7Hz, 6H). 13 C NMR (101MHz, CDCl 3 ) δ 158.8, 147.3, 145.6, 131.6, 130.9, 129.9, 129.7, 128.9, 127.7, 125.0, 124.8, 74.2, 29.9, 29.7, 25.2, 24.8, 24.7, 22.0.
2.氮杂环卡宾盐酸盐3b的合成2. Synthesis of azacyclic carbene hydrochloride 3b
在耐压封管中加入2mmol二胺化合物2a、2.1mmol氯化铵、2滴甲酸、5mL原甲酸甲酯,5mL四氢呋喃,氮气氛围下120℃反应24h。反应完毕,减压旋干溶剂,经硅胶柱层析后得到白色固体(洗脱剂:先用石油醚/二氯甲烷=2:1,再用纯乙酸乙酯)。产物产量:867mg,产率:75%。2 mmol of diamine compound 2a, 2.1 mmol of ammonium chloride, 2 drops of formic acid, 5 mL of methyl orthoformate, and 5 mL of tetrahydrofuran were added to a pressure-resistant sealed tube, and the reaction was carried out at 120 °C for 24 h under nitrogen atmosphere. After the reaction was completed, the solvent was spin-dried under reduced pressure, and a white solid was obtained after silica gel column chromatography (eluent: petroleum ether/dichloromethane=2:1, then pure ethyl acetate). Product yield: 867 mg, yield: 75%.
3.氮杂环卡宾六氟磷酸盐3c的合成3. Synthesis of azacyclic carbene hexafluorophosphate 3c
将2mmol二胺化合物2a、2.1mmol六氟磷酸铵、2滴甲酸、5mL原甲酸甲酯,5mL四氢呋喃,氮气氛围下80℃反应24h。反应完毕,减压旋干溶剂,经硅胶柱层析后得到白色固体(洗脱剂:先用石油醚/二氯甲烷=2:1,再用纯乙酸乙酯)。产物产量:963mg,产率:70%。2 mmol of diamine compound 2a, 2.1 mmol of ammonium hexafluorophosphate, 2 drops of formic acid, 5 mL of methyl orthoformate, and 5 mL of tetrahydrofuran were reacted at 80° C. for 24 h under nitrogen atmosphere. After the reaction was completed, the solvent was spin-dried under reduced pressure, and a white solid was obtained after silica gel column chromatography (eluent: petroleum ether/dichloromethane=2:1, then pure ethyl acetate). Product yield: 963 mg, yield: 70%.
(3)氮杂环卡宾钯配合物Pd-NHC-1的合成:(3) Synthesis of nitrogen heterocyclic carbene palladium complex Pd-NHC-1:
将2.1mmol氮杂环卡宾四氟硼酸盐3a、1.0mmol肉桂基氯化钯二聚体、2.1mmol叔丁醇钾混于耐压封管中,加入10mL无水四氢呋喃,氮气氛围下室温反应16小时。反应完毕,减压旋干溶剂,经硅胶柱层析后得到黄色固体(洗脱剂:石油醚/乙酸乙酯=3:1)。产物产量:1.2g,产率:75%。
1H NMR(400MHz,CDCl
3)δ7.32–7.26(m,14H),7.22–7.13(m,5H),7.05(d,J=7.3Hz,2H),5.70(s,2H),5.13(s,1H),4.46(d,J=13.1Hz,1H),3.79–3.56(m,2H),3.38–3.14(m,2H),1.65(d,J=6.2Hz,6H),1.60(d,J=6.5Hz,6H),1.36(d,J=6.2Hz,6H),1.29(s,2H),0.30(d,J=6.4Hz,6H).
13C NMR(101MHz,CDCl
3)δ209.6,148.7,146.3,137.6,137.2,135.3,129.0,128.9,128.8,128.3,128.2,127.3,126.8,124.6,124.5,109.1,75.5,29.1,28.3,26.7,26.6,24.7,24.4。HR-MS(ESI):m/z 765.3357(Calcd.[M-Cl]
+),765.3389(Found[M-Cl]
+)。
Mix 2.1 mmol of azacyclic carbene tetrafluoroborate 3a, 1.0 mmol of cinnamyl palladium chloride dimer, and 2.1 mmol of potassium tert-butoxide into a pressure-sealed tube, add 10 mL of anhydrous tetrahydrofuran, and react at room temperature under nitrogen atmosphere 16 hours. After the reaction was completed, the solvent was spin-dried under reduced pressure, and a yellow solid was obtained after silica gel column chromatography (eluent: petroleum ether/ethyl acetate=3:1). Product yield: 1.2 g, yield: 75%. 1 H NMR (400 MHz, CDCl 3 ) δ 7.32-7.26 (m, 14H), 7.22-7.13 (m, 5H), 7.05 (d, J=7.3 Hz, 2H), 5.70 (s, 2H), 5.13 ( s, 1H), 4.46 (d, J=13.1Hz, 1H), 3.79–3.56 (m, 2H), 3.38–3.14 (m, 2H), 1.65 (d, J=6.2Hz, 6H), 1.60 (d , J=6.5Hz, 6H), 1.36 (d, J=6.2Hz, 6H), 1.29 (s, 2H), 0.30 (d, J=6.4Hz, 6H). 13 C NMR (101MHz, CDCl 3 )δ209 .6,148.7,146.3,137.6,137.2,135.3,129.0,128.9,128.8,128.3,128.2,127.3,126.8,124.6,124.5,109.1,75.5,29.1,28.3,26.7,26.6,24.7,24. HR-MS (ESI): m/z 765.3357 (Calcd. [M-Cl] + ), 765.3389 (Found [M-Cl] + ).
实施例2:氮杂环卡宾钯配合物Pd-NHC-2的合成Example 2: Synthesis of nitrogen heterocyclic carbene palladium complex Pd-NHC-2
(1)二胺化合物2b的合成:(1) Synthesis of diamine compound 2b:
将5mmol的(1S,2S)-(-)-1,2-二苯基乙二胺、18mmol的tBuONa、15mmol的2,4,6-三异丙基溴苯、1.5mmol的IPrMe·HCl、0.5mmol的Pd(dba)
2混合,加入20mL无水甲苯,氮气氛围下110℃反应24h。反应完毕,加水稀释,乙酸乙酯萃取3次,无水Na
2SO
4干燥。减压旋干溶剂,粗产品经硅胶柱层析后得到白色固体(洗脱剂:石油醚/二氯甲烷=10:1)。产物产量:2.15g,产率:70%。
1H NMR(400MHz,CDCl
3)δ7.10–6.94(m,10H),6.86(s,4H),4.57(d,J=4.3Hz,2H),4.18(s,2H),3.45–3.13(m,4H),2.95–2.63(m,2H),1.33–1.12(m,24H),0.87(d,J=6.8Hz,12H).
13C NMR(101MHz,CDCl
3)δ143.7,143.0,140.5,139.0,128.5,127.7,126.8,121.2,69.2,33.8,27.8,24.4,24.1,24.0,23.6。
5 mmol of (1S,2S)-(-)-1,2-diphenylethylenediamine, 18 mmol of tBuONa, 15 mmol of 2,4,6-triisopropylbromobenzene, 1.5 mmol of IPrMe·HCl, 0.5 mmol of Pd(dba) 2 was mixed, 20 mL of anhydrous toluene was added, and the reaction was carried out at 110° C. for 24 h under nitrogen atmosphere. The reaction was completed, diluted with water, extracted with ethyl acetate three times, and dried over anhydrous Na 2 SO 4 . The solvent was spin-dried under reduced pressure, and the crude product was subjected to silica gel column chromatography to obtain a white solid (eluent: petroleum ether/dichloromethane=10:1). Product yield: 2.15 g, yield: 70%. 1 H NMR (400MHz, CDCl 3 ) δ 7.10-6.94(m, 10H), 6.86(s, 4H), 4.57(d, J=4.3Hz, 2H), 4.18(s, 2H), 3.45-3.13( m, 4H), 2.95–2.63 (m, 2H), 1.33–1.12 (m, 24H), 0.87 (d, J=6.8Hz, 12H). 13 C NMR (101MHz, CDCl 3 )δ143.7,143.0,140.5, 139.0, 128.5, 127.7, 126.8, 121.2, 69.2, 33.8, 27.8, 24.4, 24.1, 24.0, 23.6.
(2)氮杂环卡宾四氟硼酸盐3d的合成:(2) Synthesis of azacyclic carbene tetrafluoroborate 3d:
在耐压封管中加入2mmol二胺化合物2b、2.1mmol四氟硼酸铵、2滴甲酸、5mL原甲酸甲酯,氮气氛围下120℃反应24h。反应完毕,减压旋干溶剂,经硅胶柱层析后得到白色固体(洗脱剂:先用石油醚/二氯甲烷=2:1,再用纯乙酸乙酯)。产物产量:1.4g,产率:90%。
1H NMR(400MHz,CDCl
3)δ8.53(s,1H),7.44–7.35(m,6H),7.32–7.23(m,4H),7.16(d,J=1.9Hz,2H),6.86(d,J=1.9Hz,2H),5.90(s,2H),3.27–3.14(m,2H),2.96–2.81(m,2H),2.66–2.59(m,2H),1.71(d,J=6.8Hz,6H),1.44(d,J=6.8Hz,6H),1.23(dd,J=6.9,2.0Hz,12H),1.10(d,J=6.9Hz,6H),0.44(d,J=6.7Hz,6H).
13C NMR(101MHz,CDCl
3)δ158.1,152.3,146.9,145.3,130.9,129.9,129.7,129.0,125.3,123.0,122.8,74.3,34.1,29.9,29.6,25.5,25.0,24.7,23.7,23.6,22.0。
2 mmol of diamine compound 2b, 2.1 mmol of ammonium tetrafluoroborate, 2 drops of formic acid, and 5 mL of methyl orthoformate were added to a pressure-resistant sealed tube, and the reaction was carried out at 120° C. for 24 h under nitrogen atmosphere. After the reaction was completed, the solvent was spin-dried under reduced pressure, and a white solid was obtained after silica gel column chromatography (eluent: petroleum ether/dichloromethane=2:1, then pure ethyl acetate). Product yield: 1.4 g, yield: 90%. 1 H NMR (400MHz, CDCl 3 ) δ 8.53 (s, 1H), 7.44-7.35 (m, 6H), 7.32-7.23 (m, 4H), 7.16 (d, J=1.9Hz, 2H), 6.86 ( d, J=1.9Hz, 2H), 5.90 (s, 2H), 3.27–3.14 (m, 2H), 2.96–2.81 (m, 2H), 2.66–2.59 (m, 2H), 1.71 (d, J= 6.8Hz,6H),1.44(d,J=6.8Hz,6H),1.23(dd,J=6.9,2.0Hz,12H),1.10(d,J=6.9Hz,6H),0.44(d,J= 6.7Hz, 6H). 13 C NMR (101MHz, CDCl 3 )δ158.1, 152.3, 146.9, 145.3, 130.9, 129.9, 129.7, 129.0, 125.3, 123.0, 122.8, 74.3, 34.1, 29.9, 29.6, 25.5, 25.0, 24 , 23.7, 23.6, 22.0.
(3)氮杂环卡宾钯配合物Pd-NHC-2的合成:(3) Synthesis of nitrogen heterocyclic carbene palladium complex Pd-NHC-2:
将2.1mmol氮杂环卡宾四氟硼酸盐3d、1.0mmol肉桂基氯化钯二聚体、2.1mmol叔丁醇钾混于耐压封管中,加入10mL无水四氢呋喃,氮气氛围下室温反应16小时。反应完毕,减压旋干溶剂,经硅胶柱层析后得到黄色固体(洗脱剂:石油醚/乙酸乙酯=3:1)。产物产量:1.3g,产率:70%。
1H NMR(400MHz,CDCl
3)δ7.27–7.22(m,12H),7.20–7.15(m,3H),7.09(s,2H),6.86(s,2H),5.66(s,2H),5.09(s,1H),4.44(d,J=13.1Hz,1H),3.76–3.57(m,2H),3.36–3.14(m,2H),2.96–2.78(m,2H),1.61(d,J=6.2Hz,6H),1.57(d,J=6.5Hz,6H),1.32(d,J=6.3Hz,6H),1.29(s,2H),1.26(d,J=6.7Hz,12H),0.24(d,J=6.5Hz,6H).
13C NMR(101MHz,CDCl
3)δ210.2,148.8,148.3,145.9,137.8,137.4,133.2,128.8,128.6,128.3,128.2,127.2,126.7,122.4,122.2,109.0,75.3,33.9,29.0,28.3,26.6,26.5,24.7,24.3,24.0,23.9。HR-MS(ESI):m/z 849.4333(Calcd.[M-Cl]
+),849.4332(Found[M-Cl]
+)。
Mix 2.1 mmol of azacyclic carbene tetrafluoroborate 3d, 1.0 mmol of cinnamyl palladium chloride dimer, and 2.1 mmol of potassium tert-butoxide into a pressure-sealed tube, add 10 mL of anhydrous tetrahydrofuran, and react at room temperature under nitrogen atmosphere 16 hours. After the reaction was completed, the solvent was spin-dried under reduced pressure, and a yellow solid was obtained after silica gel column chromatography (eluent: petroleum ether/ethyl acetate=3:1). Product yield: 1.3 g, yield: 70%. 1 H NMR (400MHz, CDCl 3 ) δ 7.27-7.22(m, 12H), 7.20-7.15(m, 3H), 7.09(s, 2H), 6.86(s, 2H), 5.66(s, 2H), 5.09(s, 1H), 4.44(d, J=13.1Hz, 1H), 3.76-3.57(m, 2H), 3.36-3.14(m, 2H), 2.96-2.78(m, 2H), 1.61(d, J=6.2Hz, 6H), 1.57(d, J=6.5Hz, 6H), 1.32(d, J=6.3Hz, 6H), 1.29(s, 2H), 1.26(d, J=6.7Hz, 12H) ,0.24(d,J=6.5Hz,6H). 13 C NMR(101MHz, CDCl 3 )δ210.2,148.8,148.3,145.9,137.8,137.4,133.2,128.8,128.6,128.3,128.2,127.2,126.7,122.4, 122.2, 109.0, 75.3, 33.9, 29.0, 28.3, 26.6, 26.5, 24.7, 24.3, 24.0, 23.9. HR-MS (ESI): m/z 849.4333 (Calcd. [M-Cl] + ), 849.4332 (Found [M-Cl] + ).
实施例3:氮杂环卡宾钯配合物Pd-NHC-3的合成Example 3: Synthesis of nitrogen heterocyclic carbene palladium complex Pd-NHC-3
(1)二胺化合物2c的合成:(1) Synthesis of diamine compound 2c:
将5mmol的(1S,2S)-1,2-双(4-(二甲胺)苯基)乙烷-1,2-二胺、18mmol的tBuONa、15mmol的2,6-二异丙基溴苯、1.5mmol的IPrMe·HCl、0.5mmol的Pd(dba)
2混合,加入20mL无水甲苯,氮气氛围下110℃反应24h。反应完毕,加水稀释,乙酸乙酯萃取3次,无水Na
2SO
4干燥。减压旋干溶剂,粗产品经硅胶柱层析后得到白色固体(洗脱剂:石油醚/二氯甲烷=10:1)。产物产量:1.85g,产率:61%。
5 mmol of (1S,2S)-1,2-bis(4-(dimethylamino)phenyl)ethane-1,2-diamine, 18 mmol of tBuONa, 15 mmol of 2,6-diisopropyl bromide Benzene, 1.5 mmol of IPrMe·HCl, and 0.5 mmol of Pd(dba) 2 were mixed, 20 mL of anhydrous toluene was added, and the reaction was carried out at 110° C. for 24 h under nitrogen atmosphere. The reaction was completed, diluted with water, extracted with ethyl acetate three times, and dried over anhydrous Na 2 SO 4 . The solvent was spin-dried under reduced pressure, and the crude product was subjected to silica gel column chromatography to obtain a white solid (eluent: petroleum ether/dichloromethane=10:1). Product yield: 1.85 g, yield: 61%.
(2)氮杂环卡宾四氟硼酸盐3e的合成:(2) Synthesis of azacyclic carbene tetrafluoroborate 3e:
在耐压封管中加入2mmol二胺化合物2c、2.1mmol四氟硼酸铵、2滴甲酸、5mL原甲酸甲酯,氮气氛围下120℃反应24h。反应完毕,减压旋干溶剂,经硅胶柱层析后得到白色固体(洗脱剂:先用石油醚/二氯甲烷=2:1,再用纯乙酸乙酯)。产物产量:1.1g,产率:90%。2 mmol of diamine compound 2c, 2.1 mmol of ammonium tetrafluoroborate, 2 drops of formic acid, and 5 mL of methyl orthoformate were added to a pressure-sealed tube, and the reaction was carried out at 120° C. for 24 h under nitrogen atmosphere. After the reaction was completed, the solvent was spin-dried under reduced pressure, and a white solid was obtained after silica gel column chromatography (eluent: petroleum ether/dichloromethane=2:1, then pure ethyl acetate). Product yield: 1.1 g, yield: 90%.
(3)氮杂环卡宾钯配合物Pd-NHC-3的合成:(3) Synthesis of nitrogen heterocyclic carbene palladium complex Pd-NHC-3:
将2.1mmol氮杂环卡宾四氟硼酸盐3e、1.0mmol肉桂基氯化钯二聚体、2.1mmol叔丁醇钾混于耐压封管中,加入10mL无水四氢呋喃,氮气氛围下室温反应16小时。反应完毕,减压旋干溶剂,经硅胶柱层析后得到黄色固体(洗脱剂:石油醚/乙酸乙酯=3:1)。产物产量:1.0g,产率:56%。Mix 2.1 mmol of azacyclic carbene tetrafluoroborate 3e, 1.0 mmol of cinnamyl palladium chloride dimer, and 2.1 mmol of potassium tert-butoxide into a pressure-sealed tube, add 10 mL of anhydrous tetrahydrofuran, and react at room temperature under nitrogen atmosphere 16 hours. After the reaction was completed, the solvent was spin-dried under reduced pressure, and a yellow solid was obtained after silica gel column chromatography (eluent: petroleum ether/ethyl acetate=3:1). Product yield: 1.0 g, yield: 56%.
实施例4:氮杂环卡宾钯配合物Pd-NHC-4的合成Example 4: Synthesis of nitrogen heterocyclic carbene palladium complex Pd-NHC-4
(1)二胺化合物2d的合成:(1) Synthesis of diamine compound 2d:
将5mmol的(1S,2S)-1-(4-硝基苯基)-2-苯乙烷-1,2-二胺、18mmol的tBuONa、15mmol的2,6-二异丙基溴苯、1.5mmol的IPrMe·HCl、0.5mmol的Pd(dba)
2混合,加入20mL无水甲苯,氮气氛围下110℃反应24h。反应完毕,加水稀释,乙酸乙酯萃取3次,无水Na
2SO
4干燥。减压旋干溶剂,粗产品经硅胶柱层析后得到白色固体(洗脱剂:石油醚/二氯甲烷=10:1)。产物产量:1.81g,产率:63%。
5mmol of (1S,2S)-1-(4-nitrophenyl)-2-phenylethane-1,2-diamine, 18mmol of tBuONa, 15mmol of 2,6-diisopropylbromobenzene, 1.5 mmol of IPrMe·HCl and 0.5 mmol of Pd(dba) 2 were mixed, 20 mL of anhydrous toluene was added, and the reaction was carried out at 110° C. for 24 h under nitrogen atmosphere. The reaction was completed, diluted with water, extracted with ethyl acetate three times, and dried over anhydrous Na 2 SO 4 . The solvent was spin-dried under reduced pressure, and the crude product was subjected to silica gel column chromatography to obtain a white solid (eluent: petroleum ether/dichloromethane=10:1). Product yield: 1.81 g, yield: 63%.
(2)氮杂环卡宾六氟磷酸盐3f的合成:(2) Synthesis of azacyclic carbene hexafluorophosphate 3f:
在耐压封管中加入2mmol二胺化合物2d、2.1mmol六氟磷酸铵、2滴甲酸、5mL原甲酸甲酯,氮气氛围下120℃反应24h。反应完毕,减压旋干溶剂,经硅胶柱层析后得到白色固体(洗脱剂:先用石油醚/二氯甲烷=2:1,再用纯乙酸乙酯)。产物产量:1.29g,产率:88%。2 mmol of diamine compound 2d, 2.1 mmol of ammonium hexafluorophosphate, 2 drops of formic acid, and 5 mL of methyl orthoformate were added to a pressure-resistant sealed tube, and the reaction was carried out at 120° C. for 24 h under nitrogen atmosphere. After the reaction was completed, the solvent was spin-dried under reduced pressure, and a white solid was obtained after silica gel column chromatography (eluent: petroleum ether/dichloromethane=2:1, then pure ethyl acetate). Product yield: 1.29 g, yield: 88%.
(3)氮杂环卡宾钯配合物Pd-NHC-4的合成:(3) Synthesis of nitrogen heterocyclic carbene palladium complex Pd-NHC-4:
将2.1mmol氮杂环卡宾六氟磷酸盐3f、1.0mmol烯丙基氯化钯二聚体、2.1mmol叔丁醇钾混于耐压封管中,加入10mL无水四氢呋喃,氮气氛围下室温反应16小时。反应完毕,减压旋干溶剂,经硅胶柱层析后得到黄色固体(洗脱剂:石油醚/乙酸乙酯=3:1)。产物产量:1.05g,产率:67%。Mix 2.1 mmol of azacyclic carbene hexafluorophosphate 3f, 1.0 mmol of allyl palladium chloride dimer, and 2.1 mmol of potassium tert-butoxide into a pressure-sealed tube, add 10 mL of anhydrous tetrahydrofuran, and react at room temperature under nitrogen atmosphere 16 hours. After the reaction was completed, the solvent was spin-dried under reduced pressure, and a yellow solid was obtained after silica gel column chromatography (eluent: petroleum ether/ethyl acetate=3:1). Product yield: 1.05 g, yield: 67%.
实施例5:氮杂环卡宾钯配合物Pd-NHC-5的合成Example 5: Synthesis of nitrogen heterocyclic carbene palladium complex Pd-NHC-5
(1)单胺化合物2e-1的合成:(1) Synthesis of monoamine compound 2e-1:
将5mmol(1S,2S)-(-)-1,2-二苯基乙二胺、9mmol的tBuONa、6mmol的2,6-二异丙基-4-甲氧基溴苯、1.5mmol的IPrMe·HCl、0.5mmol的Pd(dba)
2混合,加入20mL无水甲苯,氮气氛围下110℃反应24h。反应完毕,加水稀释,乙酸乙酯萃取3次,无水Na
2SO
4干燥。减压旋干溶剂,粗产品经硅胶柱层析后得到白色固体(洗脱剂:石油醚/二氯甲烷=10:1)。产物产量:1.4g,产率:70%。
5mmol (1S,2S)-(-)-1,2-diphenylethylenediamine, 9mmol of tBuONa, 6mmol of 2,6-diisopropyl-4-methoxybromobenzene, 1.5mmol of IPrMe ·HCl and 0.5 mmol of Pd(dba) 2 were mixed, 20 mL of anhydrous toluene was added, and the reaction was carried out at 110° C. for 24 h under nitrogen atmosphere. The reaction was completed, diluted with water, extracted with ethyl acetate three times, and dried over anhydrous Na 2 SO 4 . The solvent was spin-dried under reduced pressure, and the crude product was subjected to silica gel column chromatography to obtain a white solid (eluent: petroleum ether/dichloromethane=10:1). Product yield: 1.4 g, yield: 70%.
(2)二胺化合物2e的合成:(2) Synthesis of diamine compound 2e:
将5mmol化合物2e-1、9mmol的tBuONa、6mmol的2,6-二异丙基-溴苯、1.5mmol的IPrMe·HCl、0.5mmol的Pd(dba)
2混合,加入20mL无水甲苯,氮气氛围下110℃反应24h。反应完毕,加水稀释,乙酸乙酯萃取3次,无水Na
2SO
4干燥。减压旋干溶剂,粗产品经硅胶柱层析后得到白色固体(洗脱剂:石油醚/二氯甲烷=10:1)。产物产量:1.82g,产率:65%。
Mix 5 mmol of compound 2e-1, 9 mmol of tBuONa, 6 mmol of 2,6-diisopropyl-bromobenzene, 1.5 mmol of IPrMe HCl, 0.5 mmol of Pd(dba) 2 , add 20 mL of anhydrous toluene, under nitrogen atmosphere The reaction was carried out at 110°C for 24h. The reaction was completed, diluted with water, extracted with ethyl acetate three times, and dried over anhydrous Na 2 SO 4 . The solvent was spin-dried under reduced pressure, and the crude product was subjected to silica gel column chromatography to obtain a white solid (eluent: petroleum ether/dichloromethane=10:1). Product yield: 1.82 g, yield: 65%.
(3)氮杂环卡宾三氟乙酸盐3g的合成:(3) Synthesis of azacyclic carbene trifluoroacetate 3g:
在耐压封管中加入2mmol二胺化合物2e、2.1mmol三氟乙酸铵、2滴甲酸、5mL原甲酸甲酯,氮气氛围下120℃反应24h。反应完毕,减压旋干溶剂,经硅胶柱层析后得到白色固体(洗脱剂:先用石油醚/二氯甲烷=2:1,再用纯乙酸乙酯)。产物产量:1.05g,产率:79%。2 mmol of diamine compound 2e, 2.1 mmol of ammonium trifluoroacetate, 2 drops of formic acid, and 5 mL of methyl orthoformate were added to a pressure-resistant sealed tube, and the reaction was carried out at 120° C. for 24 h under nitrogen atmosphere. After the reaction was completed, the solvent was spin-dried under reduced pressure, and a white solid was obtained after silica gel column chromatography (eluent: petroleum ether/dichloromethane=2:1, then pure ethyl acetate). Product yield: 1.05 g, yield: 79%.
(4)氮杂环卡宾钯配合物Pd-NHC-5的合成:(4) Synthesis of nitrogen heterocyclic carbene palladium complex Pd-NHC-5:
将2.1mmol氮杂环卡宾三氟乙酸盐3g、1.0mmol肉桂基氯化钯二聚体、2.1mmol叔丁醇钾混于耐压封管中,加入10mL无水四氢呋喃,氮气氛围下室温反应16h。反应完毕,减压旋干溶剂,经硅胶柱层析后得到黄色固体(洗脱剂:石油醚/乙酸乙酯=3:1)。产物产量:1.05g, 产率:60%。3 g of 2.1 mmol azacyclic carbene trifluoroacetate, 1.0 mmol of cinnamyl palladium chloride dimer, and 2.1 mmol of potassium tert-butoxide were mixed in a pressure-sealed tube, 10 mL of anhydrous tetrahydrofuran was added, and the reaction was carried out at room temperature under nitrogen atmosphere. 16h. After the reaction was completed, the solvent was spin-dried under reduced pressure, and a yellow solid was obtained after silica gel column chromatography (eluent: petroleum ether/ethyl acetate=3:1). Product yield: 1.05 g, yield: 60%.
实施例6:参照实施例1的步骤,除了将(1S,2S)-(-)-1,2-二苯基乙二胺替换为(1R,2R)-(-)-1,2-二苯基乙二胺,其他原料及步骤相同,最终制备得到氮杂环卡宾钯配合物Pd-NHC-1’。Pd-NHC-1’核磁数据如下:
1H NMR(400MHz,CDCl
3)δ7.35–7.27(m,14H),7.22–7.11(m,5H),7.05(d,J=7.5Hz,2H),5.69(s,2H),5.12(s,1H),4.46(d,J=13.1Hz,1H),3.82–3.56(m,2H),3.38–3.14(m,2H),1.65(d,J=6.2Hz,6H),1.62(d,J=6.5Hz,6H),1.35(d,J=6.2Hz,6H),1.30(s,2H),0.30(d,J=6.4Hz,6H).
13C NMR(101MHz,CDCl
3)δ209.7,148.7,146.3,137.5,137.2,135.3,129.0,128.9,128.8,128.3,128.2,127.3,126.9,124.6,124.5,109.0,75.5,29.1,28.3,26.7,26.6,24.7,24.4。HR-MS(ESI):m/z 765.3357(Calcd.[M-Cl]
+),765.3379(Found[M-Cl]
+)。
Example 6: Follow the procedure of Example 1, except replace (1S,2S)-(-)-1,2-diphenylethylenediamine with (1R,2R)-(-)-1,2-diamine Phenylethylenediamine, other raw materials and steps are the same, and finally the azacyclic carbene palladium complex Pd-NHC-1' is prepared. The NMR data of Pd-NHC-1' are as follows: 1 H NMR (400MHz, CDCl 3 )δ7.35-7.27(m,14H),7.22-7.11(m,5H),7.05(d,J=7.5Hz,2H) , 5.69(s, 2H), 5.12(s, 1H), 4.46(d, J=13.1Hz, 1H), 3.82–3.56(m, 2H), 3.38–3.14(m, 2H), 1.65(d, J =6.2Hz,6H),1.62(d,J=6.5Hz,6H),1.35(d,J=6.2Hz,6H),1.30(s,2H),0.30(d,J=6.4Hz,6H). 13 C NMR (101 MHz, CDCl 3 ) δ 209.7, 148.7, 146.3, 137.5, 137.2, 135.3, 129.0, 128.9, 128.8, 128.3, 128.2, 127.3, 126.9, 124.6, 124.5, 109.0, 75.5, 296.1, 28 , 24.7, 24.4. HR-MS (ESI): m/z 765.3357 (Calcd. [M-Cl] + ), 765.3379 (Found [M-Cl] + ).
采用消旋的1,2-二苯基乙二胺为起始原料,则可得到消旋的氮杂环卡宾钯配合物rac-Pd-NHC-1。rac-Pd-NHC-1核磁数据如下:
1H NMR(400MHz,CDCl
3)δ7.35–7.25(m,14H),7.22–7.08(m,5H),7.05(d,J=7.3Hz,2H),5.70(s,2H),5.11(s,1H),4.45(d,J=13.2Hz,1H),3.78–3.53(m,2H),3.38–3.11(m,2H),1.67(d,J=6.3Hz,6H),1.60(d,J=6.5Hz,6H),1.36(d,J=6.2Hz,6H),1.29(s,2H),0.31(d,J=6.3Hz,6H).
13C NMR(101MHz,CDCl
3)δ209.6,148.8,146.1,137.6,137.2,135.2,129.0,128.9,128.8,128.3,128.2,127.2,126.7,124.6,124.5,109.1,75.4,29.1,28.2,26.7,26.6,24.7,24.4。HR-MS(ESI):m/z 765.3357(Calcd.[M-Cl]
+),765.3384(Found[M-Cl]
+)。
Using racemic 1,2-diphenylethylenediamine as the starting material, the racemic azacyclic carbene palladium complex rac-Pd-NHC-1 can be obtained. The nuclear magnetic data of rac-Pd-NHC-1 are as follows: 1 H NMR (400MHz, CDCl 3 )δ7.35-7.25(m,14H),7.22-7.08(m,5H),7.05(d,J=7.3Hz,2H ), 5.70(s, 2H), 5.11(s, 1H), 4.45(d, J=13.2Hz, 1H), 3.78–3.53(m, 2H), 3.38–3.11(m, 2H), 1.67(d, J=6.3Hz,6H),1.60(d,J=6.5Hz,6H),1.36(d,J=6.2Hz,6H),1.29(s,2H),0.31(d,J=6.3Hz,6H) . 13 C NMR (101MHz, CDCl 3 )δ209.6,148.8,146.1,137.6,137.2,135.2,129.0,128.9,128.8,128.3,128.2,127.2,126.7,124.6,124.5,109.1,7,5.4,29.1 26.6, 24.7, 24.4. HR-MS (ESI): m/z 765.3357 (Calcd. [M-Cl] + ), 765.3384 (Found [M-Cl] + ).
根据化学基本原理,改变起始原料取代或未取代的二苯基乙二胺的构型,其它原料和合成方法不变,可制得其对映的卡宾钯配合物或消旋体。在反应产物非手性的条件下,采用相反构型、对映的光学纯氮杂环卡宾钯配合物以及消旋的氮杂环卡宾钯配合物所得催化反应结果相当;而产物为手性化合物时,不同构型的手性催化剂则会产生对应的不对称催化结果。因此,本文中卡宾钯催化剂的对映体和消旋体的催化效果分别选择Pd-NHC-1’和rac-Pd-NHC-1为代表作为Pd-NHC-1的对比进行说明。According to the basic principle of chemistry, the configuration of the substituted or unsubstituted diphenylethylenediamine of the starting material is changed, and other raw materials and synthesis methods remain unchanged, and the enantiomeric carbene palladium complex or racemate can be obtained. Under the condition that the reaction product is achiral, the catalytic reaction results obtained by adopting the opposite configuration and enantiomeric optically pure nitrogen-heterocyclic carbene palladium complex and racemic nitrogen-heterocyclic carbene palladium complex are equivalent; and the product is a chiral compound When , different configurations of chiral catalysts will produce corresponding asymmetric catalytic results. Therefore, in this paper, Pd-NHC-1' and rac-Pd-NHC-1 are selected as the representative of the catalytic effect of the enantiomer and racemate of the carbene palladium catalyst to illustrate the comparison of Pd-NHC-1.
实施例7:索尼吉布的合成Example 7: Synthesis of Sonny Gibb
目前已经报道的合成路线,不仅合成路线繁多,而且均需要进行钯碳加氢还原,再加上起始原料价格昂贵,对工业化生产带来了一定的限制。因此,设计和开发新的、简洁经济的合成路线,对于索尼吉布的工业化生产具有重要的现实意义。如下所示,本发明路线合成步骤少、收率高,避免了钯碳加氢过程,可在室温条件下进行反应,从而更安全,成本更低,适用于工 业化大生产。The synthetic routes that have been reported so far not only have many synthetic routes, but also all require palladium-carbon hydrogenation reduction, and the starting materials are expensive, which brings certain restrictions to industrial production. Therefore, the design and development of a new, concise and economical synthesis route has important practical significance for the industrial production of Sony Gibbs. As shown below, the route of the present invention has few synthetic steps and high yield, avoids the palladium-carbon hydrogenation process, and can react at room temperature, thereby being safer, having lower cost, and being suitable for large-scale industrial production.
(1)化合物I的合成:(1) Synthesis of compound I:
氮气下,将3-溴-2-甲基苯甲酸(1.0mmol),4-(三氟甲氧基)苯硼酸(2.0mmol),碳酸钠(4.0mmol),Pd(PPh
3)
4(0.05mmol),4mL DME,1mL水混合,130℃下反应12h。反应完毕,加水稀释,乙酸乙酯萃取3次,减压旋干,无水硫酸钠干燥,经硅胶柱层析后得到白色固体,得到90%(266.3mg)的产率。
Under nitrogen, 3-bromo-2-methylbenzoic acid (1.0 mmol), 4-(trifluoromethoxy)benzeneboronic acid (2.0 mmol), sodium carbonate (4.0 mmol), Pd( PPh3 ) 4 (0.05 mmol), 4 mL of DME, and 1 mL of water were mixed and reacted at 130 °C for 12 h. After the reaction was completed, it was diluted with water, extracted three times with ethyl acetate, spin-dried under reduced pressure, dried over anhydrous sodium sulfate, and subjected to silica gel column chromatography to obtain a white solid with a yield of 90% (266.3 mg).
(2)化合物II的合成(2) Synthesis of Compound II
将化合物I(1.0mmol),5-氨基-2-氯吡啶(1.0mmol),HAUT(2.0mmol,410mg),三乙胺(4.0mmol),4mL DMF混合,室温下反应12h。反应完毕,加水稀释,乙酸乙酯萃取3次,减压旋干,无水硫酸钠干燥,经硅胶柱层析后得到白色固体,得到产率92%(373.3mg)的II。Compound I (1.0 mmol), 5-amino-2-chloropyridine (1.0 mmol), HAUT (2.0 mmol, 410 mg), triethylamine (4.0 mmol), and 4 mL of DMF were mixed and reacted at room temperature for 12 h. The reaction was completed, diluted with water, extracted with ethyl acetate three times, spin-dried under reduced pressure, and dried over anhydrous sodium sulfate. After silica gel column chromatography, a white solid was obtained, and II in a yield of 92% (373.3 mg) was obtained.
(3)化合物III的合成(3) Synthesis of compound III
将化合物II(1.0mmol,1.0equiv)、(2S,6R)-2,6-二甲基吗啉(1.2equiv)、NHC-钯催化体系(5mol%)、叔丁醇钠(1.2equiv)、4mL乙二醇二甲醚,封闭瓶口,25-100℃氮气条件下搅拌16h。加水稀释,乙酸乙酯萃取3次,减压旋干,无水硫酸钠干燥,经硅胶柱层析后得到白色固体,得到产物III。产物谱学数据:
1H NMR(400MHz,CDCl
3)δ8.20(d,J=2.6Hz,1H),8.03(dd,J=9.1,2.7Hz,1H),7.54(s,1H),7.46(dd,J=5.7,3.3Hz,1H),7.33–7.23(m,6H),6.66(d,J=9.1Hz,1H),3.99(dd,J=12.7,1.7Hz,2H),3.76–3.68(m,2H),2.50(dd,J=12.5,10.7Hz,2H),2.32(s,3H),1.26(d,J=6.3Hz,6H).
13C NMR(101MHz,CDCl
3)δ168.5,156.8,148.4,142.2,140.1,139.8,137.6,133.4,131.5,131.2,130.5,126.0,125.8,125.6,121.7,120.6, 119.2,106.8,71.5,51.1,18.9,17.5。
Compound II (1.0 mmol, 1.0 equiv), (2S,6R)-2,6-dimethylmorpholine (1.2 equiv), NHC-palladium catalytic system (5 mol%), sodium tert-butoxide (1.2 equiv), 4 mL of ethylene glycol dimethyl ether, closed the bottle, and stirred at 25-100 °C for 16 h under nitrogen. Add water to dilute, extract 3 times with ethyl acetate, spin dry under reduced pressure, dry with anhydrous sodium sulfate, and obtain white solid after silica gel column chromatography to obtain product III. Product Spectroscopic Data: 1 H NMR (400 MHz, CDCl 3 ) δ 8.20 (d, J=2.6 Hz, 1H), 8.03 (dd, J=9.1, 2.7 Hz, 1H), 7.54 (s, 1H), 7.46 (dd, J=5.7, 3.3Hz, 1H), 7.33–7.23 (m, 6H), 6.66 (d, J=9.1Hz, 1H), 3.99 (dd, J=12.7, 1.7Hz, 2H), 3.76– 3.68(m, 2H), 2.50(dd, J=12.5, 10.7Hz, 2H), 2.32(s, 3H), 1.26(d, J=6.3Hz, 6H). 13 C NMR (101MHz, CDCl 3 )δ168 .5, 156.8, 148.4, 142.2, 140.1, 139.8, 137.6, 133.4, 131.5, 131.2, 130.5, 126.0, 125.8, 125.6, 121.7, 120.6, 119.2, 106.8, 71.5, 51.1, 18.9, 17.5.
其中,当采用本发明的Pd-NHC-1催化反应时,用量为5mol%,室温氮气条件下反应16h,产率高达90%。Wherein, when using the Pd-NHC-1 catalyzed reaction of the present invention, the dosage is 5 mol%, and the reaction is carried out for 16 hours under the condition of nitrogen at room temperature, and the yield is as high as 90%.
(4)以不同的膦配体/钯催化体系进行由化合物II到III的催化合成,控制膦配体(L1-L8)用量为5mol%,钯的用量为5mol%,100℃氮气条件下搅拌72h,所用膦配体结构式及产率如下所示。(4) Catalytic synthesis from compound II to III is carried out with different phosphine ligand/palladium catalytic systems, the amount of phosphine ligands (L1-L8) is controlled to be 5 mol%, the amount of palladium is 5 mol%, and stirring is performed under nitrogen conditions at 100° C. For 72h, the structural formula and yield of the phosphine ligands used are shown below.
反应方程式如下所示:The reaction equation is as follows:
各催化体系膦配体结构示意及催化效率如下所示:The structure and catalytic efficiency of the phosphine ligands of each catalytic system are shown as follows:
专利文献WO2011009852的总收率为42.8%,专利文献WO2017163258的总收率为63.1%,专利文献CN105330658A的总收率为15.1%,专利文献CN109293649A的总收率为58.5%,本发明合成方法采用Pd-NHC-1催化时总收率为74.5%。The total yield of the patent document WO2011009852 is 42.8%, the total yield of the patent document WO2017163258 is 63.1%, the total yield of the patent document CN105330658A is 15.1%, the total yield of the patent document CN109293649A is 58.5%, the synthesis method of the present invention adopts Pd The total yield when catalyzed by -NHC-1 was 74.5%.
本发明合成方法中应用本发明的大位阻氮杂环卡宾钯配合物(NHC-Pd),首次实现了在室温条件下催化芳杂环氯代物与芳杂环胺的高效C-N偶联,且合成步骤少、收率高,避免了钯碳加氢过程,可在室温条件下进行反应,从而更安全,成本更低,适用于工业化大生产。In the synthesis method of the present invention, the large sterically hindered nitrogen heterocyclic carbene palladium complex (NHC-Pd) of the present invention is used to realize the efficient C-N coupling of aromatic heterocyclic chloride and aromatic heterocyclic amine for the first time at room temperature, and The synthesis steps are few, the yield is high, the palladium-carbon hydrogenation process is avoided, and the reaction can be carried out at room temperature, thereby being safer and lower in cost, and suitable for industrialized large-scale production.
实施例8:利用本发明实施例1-实施例6的催化剂及现有的本领域催化剂进行催化效率的对比Example 8: Comparison of catalytic efficiency using the catalysts of Examples 1 to 6 of the present invention and existing catalysts in the art
基于实施例7的合成方法中步骤(3)中的C-N偶联反应,催化剂用量为5mol%,室温氮气条件下搅拌16h,各催化剂的催化效率见下表1。现有各催化剂的结构式如下所示:Based on the C-N coupling reaction in step (3) in the synthesis method of Example 7, the catalyst dosage was 5 mol%, and the mixture was stirred for 16 h under nitrogen at room temperature. The catalytic efficiency of each catalyst is shown in Table 1 below. The structural formula of each existing catalyst is as follows:
表1不同催化剂催化C-N偶联反应的效率Table 1 Efficiency of different catalysts for C-N coupling reaction
由表可见,相同的室温反应条件下,本发明的大位阻氮杂环卡宾钯配合物(NHC-Pd)实现了高效催化C-N偶联的效果,催化收率可高达93%。It can be seen from the table that under the same room temperature reaction conditions, the large sterically hindered nitrogen heterocyclic carbene palladium complex (NHC-Pd) of the present invention achieves the effect of efficiently catalyzing C-N coupling, and the catalytic yield can be as high as 93%.
实施例9:本发明氮杂环卡宾钯配合物应用于C-N偶联反应,与经典卡宾钯配合物催化所得收率对比,本实施例的反应(1)~反应(6)中所用的原料和溶剂为:1mmol芳(杂)环氯代物,1.2mmol胺,1.2mmol叔丁醇钠,4mL乙二醇二甲醚。Embodiment 9: The nitrogen heterocyclic carbene palladium complex of the present invention is applied to the C-N coupling reaction. Compared with the yield obtained by the catalysis of the classical carbene palladium complex, the raw materials used in the reactions (1) to (6) of this embodiment and The solvent is: 1 mmol of aryl (hetero) ring chloride, 1.2 mmol of amine, 1.2 mmol of sodium tert-butoxide, 4 mL of ethylene glycol dimethyl ether.
根据实施例1-实施例5的制备方法,制备得到不同取代基取代的本发明氮杂环卡宾钯配合物Pd-NHC-6至Pd-NHC-31,结构式如下所示:According to the preparation method of Example 1-Example 5, the azacyclic carbene palladium complexes Pd-NHC-6 to Pd-NHC-31 substituted with different substituents of the present invention are prepared, and the structural formulas are as follows:
反应(1):反应方程式如下所示,各催化剂的催化效率见下表2。Reaction (1): The reaction equation is shown below, and the catalytic efficiency of each catalyst is shown in Table 2 below.
表2不同催化剂催化C-N偶联反应的效率Table 2 Efficiency of different catalysts for C-N coupling reaction
由表可见,相同的室温反应条件下,本发明的大位阻氮杂环卡宾钯配合物(NHC-Pd)实现了高效催化C-N偶联的效果;与此相比,经典的卡宾钯配合物催化率最低仅为10%,最高也仅有75%,本发明配合物的催化率均接近90%,最高可高达99%。It can be seen from the table that under the same room temperature reaction conditions, the large sterically hindered nitrogen heterocyclic carbene palladium complex (NHC-Pd) of the present invention achieves the effect of catalyzing C-N coupling efficiently; The lowest catalytic rate is only 10%, and the highest is only 75%. The catalytic rate of the complex of the present invention is all close to 90%, and the highest can be as high as 99%.
反应(2):反应方程式如下所示,以Pd-NHC-1为例各催化剂的催化效率见下表3。Reaction (2): The reaction equation is shown below, and the catalytic efficiency of each catalyst is shown in Table 3 below by taking Pd-NHC-1 as an example.
表3不同催化剂催化C-N偶联反应的效率Table 3 Efficiency of different catalysts for C-N coupling reaction
反应(3):反应方程式如下所示,以Pd-NHC-2为例各催化剂的催化效率见下表4。Reaction (3): The reaction equation is shown below, and the catalytic efficiency of each catalyst is shown in Table 4 below by taking Pd-NHC-2 as an example.
表4不同催化剂催化C-N偶联反应的效率Table 4 Efficiency of different catalysts for C-N coupling reaction
反应(4):反应方程式如下所示,以Pd-NHC-3为例各催化剂的催化效率见下表5。Reaction (4): The reaction equation is shown below, and the catalytic efficiency of each catalyst is shown in Table 5 below by taking Pd-NHC-3 as an example.
表5不同催化剂催化C-N偶联反应的效率Table 5 Efficiency of different catalysts catalyzing C-N coupling reaction
反应(5):反应方程式如下所示,,以Pd-NHC-4为例各催化剂的催化效率见下表6。Reaction (5): The reaction equation is shown below, and the catalytic efficiency of each catalyst is shown in Table 6 below by taking Pd-NHC-4 as an example.
表6不同催化剂催化C-N偶联反应的效率Table 6 Efficiency of different catalysts for C-N coupling reaction
反应(6):反应方程式如下所示,以Pd-NHC-5为例各催化剂的催化效率见下表7。Reaction (6): The reaction equation is shown below, and the catalytic efficiency of each catalyst is shown in Table 7 below by taking Pd-NHC-5 as an example.
表7不同催化剂催化C-N偶联反应的效率Table 7 Efficiency of different catalysts for C-N coupling reaction
实施例10:本发明氮杂环卡宾钯配合物应用于C-N偶联反应合成具有潜在药理活性的化合物Example 10: The azacyclic carbene palladium complex of the present invention is applied to C-N coupling reaction to synthesize compounds with potential pharmacological activity
(1)咪唑并吡啶衍生物的合成(1) Synthesis of imidazopyridine derivatives
在N
2环境中,化合物1m(1.0mmol,1.0equiv)、化合物2m(1.2equiv)、Pd-NHC-3(5mol%)、叔丁醇钠(1.2equiv)、4mL乙二醇二甲醚,封闭瓶口,室温氮气下搅拌16小时。加水稀释,乙酸乙酯萃取3次,减压旋干,无水硫酸钠干燥,经硅胶柱层析后得到白色固体,得到89%(438.7mg)的产率。产物谱学数据:
1H NMR(400MHz,CDCl
3)δ12.16(s,1H),8.04–7.92(m,2H),7.81–7.67(m,3H),7.47–7.36(m,3H),7.29(t,J=7.4Hz,1H),6.85–6.78(m,2H),6.68–6.61(m,1H),6.54(d,J=9.4Hz,1H),6.39(d,J=7.4Hz,1H),4.23–3.98(m,2H),3.68(s,4H),2.84(s,4H),2.68–2.48(m,2H),1.96–1.73(m,4H).
13C NMR(101MHz,CDCl
3)δ164.8,161.3,143.6,141.2,140.8,140.7,140.3,134.0,129.0,128.5,127.5,125.9,118.6,117.9,114.1,112.7,112.6,108.4,106.4,98.9,68.1,58.2,53.0,49.1,27.1,23.2。
Under N2 environment, compound 1m (1.0 mmol, 1.0 equiv), compound 2m (1.2 equiv), Pd-NHC-3 (5 mol%), sodium tert-butoxide (1.2 equiv), 4 mL of ethylene glycol dimethyl ether, The bottle was closed and stirred at room temperature under nitrogen for 16 hours. Add water to dilute, extract 3 times with ethyl acetate, spin dry under reduced pressure, and dry over anhydrous sodium sulfate. After silica gel column chromatography, a white solid was obtained in a yield of 89% (438.7 mg). Product spectral data: 1 H NMR (400 MHz, CDCl 3 ) δ 12.16 (s, 1H), 8.04–7.92 (m, 2H), 7.81–7.67 (m, 3H), 7.47–7.36 (m, 3H), 7.29(t,J=7.4Hz,1H),6.85-6.78(m,2H),6.68-6.61(m,1H),6.54(d,J=9.4Hz,1H),6.39(d,J=7.4Hz ,1H),4.23–3.98(m,2H),3.68(s,4H),2.84(s,4H),2.68–2.48(m,2H),1.96–1.73(m,4H) .13C NMR(101MHz) , CDCl 3 )δ164.8,161.3,143.6,141.2,140.8,140.7,140.3,134.0,129.0,128.5,127.5,125.9,118.6,117.9,114.1,112.7,112.6,108.4,106.4,53.9. 49.1, 27.1, 23.2.
(2)黄酮类衍生物的合成(2) Synthesis of flavonoid derivatives
在N
2环境中,将化合物1l(1.0mmol,1.0equiv)、化合物2l(1.2equiv)、Pd-NHC-2(5mol%)、叔丁醇钠(1.2equiv)、4mL乙二醇二甲醚,封闭瓶口,室温氮气下搅拌16小时。加水稀释,乙酸乙酯萃取3次,减压旋干,无水硫酸钠干燥,经硅胶柱层析后得到白色固体,得到82%(361.6mg)的产率。产物谱学数据:
1H NMR(400MHz,CDCl
3)δ8.32(d,J=5.2Hz,1H),8.22(dd,J=8.0,1.5Hz,1H),7.71(ddd,J=8.7,7.2,1.7Hz,1H),7.60–7.54(m,1H),7.47–7.39(m,1H),7.26(s,1H),7.07(s,1H),7.02(dd,J=5.2,1.3Hz,1H),6.90(s,1H),6.83(s,1H),6.80–6.73(m,1H),5.95(s,2H),3.69–3.60(m,4H),3.48(s,2H),2.61–2.53(m,4H).
13C NMR(101MHz,CDCl
3)δ178.2,161.9,159.9,156.1,149.0,147.6,146.6,140.5,134.0,131.7,125.7,125.4,124.0,122.1,118.1,109.4,109.1,108.9,107.8,103.1,100.8,62.7,52.6,45.1。
Under N2 environment, compound 1l (1.0 mmol, 1.0 equiv), compound 2l (1.2 equiv), Pd-NHC-2 (5 mol%), sodium tert-butoxide (1.2 equiv), 4 mL of ethylene glycol dimethyl ether were combined , closed the bottle, and stirred at room temperature under nitrogen for 16 hours. Diluted with water, extracted three times with ethyl acetate, spin-dried under reduced pressure, dried over anhydrous sodium sulfate, and subjected to silica gel column chromatography to obtain a white solid in a yield of 82% (361.6 mg). Product Spectroscopic Data: 1 H NMR (400 MHz, CDCl 3 ) δ 8.32 (d, J=5.2 Hz, 1 H), 8.22 (dd, J=8.0, 1.5 Hz, 1 H), 7.71 (ddd, J=8.7, 7.2, 1.7Hz, 1H), 7.60–7.54 (m, 1H), 7.47–7.39 (m, 1H), 7.26 (s, 1H), 7.07 (s, 1H), 7.02 (dd, J=5.2, 1.3Hz ,1H),6.90(s,1H),6.83(s,1H),6.80–6.73(m,1H),5.95(s,2H),3.69–3.60(m,4H),3.48(s,2H), 2.61–2.53(m, 4H). 13 C NMR (101MHz, CDCl 3 )δ178.2,161.9,159.9,156.1,149.0,147.6,146.6,140.5,134.0,131.7,125.7,125.4,124.0,122.1,118.1,1 109.1, 108.9, 107.8, 103.1, 100.8, 62.7, 52.6, 45.1.
(3)Buspar的合成(3) Synthesis of Buspar
在N
2环境中,将化合物1n(1.0mmol,1.0equiv)、化合物2n(1.2equiv)、Pd-NHC-1(5mol%)、叔丁醇钠(1.2equiv)、4mL乙二醇二甲醚,封闭瓶口,室温氮气下搅拌16小时。加水稀释,乙酸乙酯萃取3次,减压旋干,无水硫酸钠干燥,经硅胶柱层析后得到白色固体,得到90%(346.8mg)的产率。其它条件不变,采用Pd-NHC-1’和rac-Pd-NHC-1代替Pd-NHC-1催化,得到的反应产率分别为91%和90%。产物谱学数据:
1H NMR(400MHz,CDCl
3)δ8.28(d,J=4.7Hz,2H),6.46(t,J=4.7Hz,1H),3.84–3.80(m,4H),3.77(t,J=6.9Hz,2H),2.57(s,4H),2.53–2.46(m,4H),2.39(d,J=6.5Hz,2H),1.74–1.64(m,4H),1.58–1.42(m,8H).
13C NMR(101MHz,CDCl
3)δ172.1,161.5,157.6,109.7,58.2,52.9,44.9,43.4,39.4,39.2,37.5,25.9,24.1,24.0。
Under N2 environment, compound 1n (1.0 mmol, 1.0 equiv), compound 2n (1.2 equiv), Pd-NHC-1 (5 mol%), sodium tert-butoxide (1.2 equiv), 4 mL of ethylene glycol dimethyl ether were combined , closed the bottle, and stirred at room temperature under nitrogen for 16 hours. Add water to dilute, extract 3 times with ethyl acetate, spin dry under reduced pressure, dry over anhydrous sodium sulfate, and obtain a white solid after silica gel column chromatography in a yield of 90% (346.8 mg). Other conditions remain unchanged, using Pd-NHC-1' and rac-Pd-NHC-1 instead of Pd-NHC-1 for catalysis, the reaction yields obtained were 91% and 90%, respectively. Product Spectroscopic Data: 1 H NMR (400 MHz, CDCl 3 ) δ 8.28 (d, J=4.7 Hz, 2H), 6.46 (t, J=4.7 Hz, 1 H), 3.84-3.80 (m, 4H), 3.77 (t, J=6.9Hz, 2H), 2.57 (s, 4H), 2.53–2.46 (m, 4H), 2.39 (d, J=6.5Hz, 2H), 1.74–1.64 (m, 4H), 1.58– 1.42 (m, 8H). 13 C NMR (101 MHz, CDCl 3 ) δ 172.1, 161.5, 157.6, 109.7, 58.2, 52.9, 44.9, 43.4, 39.4, 39.2, 37.5, 25.9, 24.1, 24.0.
(4)Piribedil的合成(4) Synthesis of Piribedil
在N
2环境中,将化合物1o(1.0mmol,1.0equiv)、化合物2o(1.2equiv)、Pd-NHC-1(2mol%)、叔丁醇钠(1.2equiv)、4mL乙二醇二甲醚,封闭瓶口,室温氮气下搅拌16小时。加水稀释,乙酸乙酯萃取3次,减压旋干,无水硫酸钠干燥,经硅胶柱层析后得到白色固体,得到98%(292.1mg)的产率。其它条件不变,采用Pd-NHC-1’和rac-Pd-NHC-1代替Pd-NHC-1催化,得到的反应产率也均为98%。产物谱学数据:
1H NMR(400MHz,CDCl
3)δ8.28(d,J=4.7Hz,2H),6.88(s,1H),6.75(s,2H),6.46(t,J=4.7Hz,1H),5.94(s,2H),3.87–3.73(m,4H),3.45(s,2H),2.54–2.40(m,4H).
13C NMR(101MHz,CDCl
3)δ161.6,157.6,147.6,146.6,131.7,122.2,109.6,109.4,107.8,100.8,62.8,52.8,43.6。
Under N2 environment, compound 1o (1.0 mmol, 1.0 equiv), compound 2o (1.2 equiv), Pd-NHC-1 (2 mol%), sodium tert-butoxide (1.2 equiv), 4 mL of ethylene glycol dimethyl ether were combined , closed the bottle, and stirred at room temperature under nitrogen for 16 hours. Add water to dilute, extract 3 times with ethyl acetate, spin dry under reduced pressure, and dry over anhydrous sodium sulfate. After silica gel column chromatography, a white solid was obtained in a yield of 98% (292.1 mg). Other conditions remain unchanged, using Pd-NHC-1' and rac-Pd-NHC-1 instead of Pd-NHC-1 for catalysis, the reaction yields obtained are also 98%. Product Spectroscopic Data: 1 H NMR (400 MHz, CDCl 3 ) δ 8.28 (d, J=4.7 Hz, 2H), 6.88 (s, 1H), 6.75 (s, 2H), 6.46 (t, J=4.7 Hz) , 1H), 5.94(s, 2H), 3.87–3.73(m, 4H), 3.45(s, 2H), 2.54–2.40(m, 4H). 13 C NMR (101MHz, CDCl 3 )δ161.6,157.6,147.6 , 146.6, 131.7, 122.2, 109.6, 109.4, 107.8, 100.8, 62.8, 52.8, 43.6.
(5)Brexpiprazole的合成(5) Synthesis of Brexpiprazole
在N
2环境中,将化合物1p(1.0mmol,1.0equiv)、化合物2p(1.2equiv)、Pd-NHC-1(5mol%)、叔丁醇钠(1.2equiv)、4mL乙二醇二甲醚,封闭瓶口,室温氮气下搅拌16小时。加水稀释,乙酸乙酯萃取3次,减压旋干,无水硫酸钠干燥,经硅胶柱层析后得到白色固体,得到95%(411.3mg)的产率。其它条件不变,采用Pd-NHC-1’和rac-Pd-NHC-1代替Pd-NHC-1 催化,得到的反应产率分别为96%和95%。产物谱学数据:
1H NMR(400MHz,CDCl
3)δ12.55(s,1H),7.72(d,J=9.4Hz,1H),7.54(d,J=8.1Hz,1H),7.46–7.36(m,3H),7.26(dd,J=8.3,7.4Hz,1H),6.88(dd,J=8.8,4.9Hz,2H),6.81(dd,J=8.7,2.3Hz,1H),6.55(d,J=9.4Hz,1H),4.11(t,J=6.2Hz,2H),3.21(s,4H),2.74(s,4H),2.60–2.49(m,2H),1.94–1.84(m,2H),1.82–1.72(m,2H).
13C NMR(101MHz,CDCl
3)δ165.0,161.3,148.4,141.0,140.8,140.4,134.0,128.9,124.9,124.8,121.8,117.8,116.9,114.1,112.6,112.1,99.0,68.1,58.2,53.5,52.0,27.1,23.3。
Under N2 environment, compound 1p (1.0 mmol, 1.0 equiv), compound 2p (1.2 equiv), Pd-NHC-1 (5 mol%), sodium tert-butoxide (1.2 equiv), 4 mL of ethylene glycol dimethyl ether were combined , closed the bottle, and stirred at room temperature under nitrogen for 16 hours. Add water to dilute, extract 3 times with ethyl acetate, spin dry under reduced pressure, and dry over anhydrous sodium sulfate. After silica gel column chromatography, a white solid was obtained in a yield of 95% (411.3 mg). Other conditions remained unchanged, and Pd-NHC-1' and rac-Pd-NHC-1 were used instead of Pd-NHC-1 for catalysis, and the reaction yields were 96% and 95%, respectively. Product Spectroscopic Data: 1 H NMR (400 MHz, CDCl 3 ) δ 12.55 (s, 1H), 7.72 (d, J=9.4 Hz, 1H), 7.54 (d, J=8.1 Hz, 1H), 7.46-7.36 (m,3H),7.26(dd,J=8.3,7.4Hz,1H),6.88(dd,J=8.8,4.9Hz,2H),6.81(dd,J=8.7,2.3Hz,1H),6.55( d, J=9.4Hz, 1H), 4.11 (t, J=6.2Hz, 2H), 3.21 (s, 4H), 2.74 (s, 4H), 2.60–2.49 (m, 2H), 1.94–1.84 (m , 2H), 1.82–1.72(m, 2H). 13 C NMR (101MHz, CDCl 3 )δ165.0,161.3,148.4,141.0,140.8,140.4,134.0,128.9,124.9,124.8,121.8,117.8,116.9,114.1, 112.6, 112.1, 99.0, 68.1, 58.2, 53.5, 52.0, 27.1, 23.3.
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。The above-mentioned embodiments are preferred embodiments of the present invention, but the embodiments of the present invention are not limited by the above-mentioned embodiments, and any other changes, modifications, substitutions, combinations, The simplification should be equivalent replacement manners, which are all included in the protection scope of the present invention.
Claims (10)
- 一种大位阻氮杂环卡宾钯配合物,其特征在于该配合物是具有式(A)所示化学结构式的化合物:A large sterically hindered nitrogen heterocyclic carbene palladium complex, characterized in that the complex is a compound with a chemical structural formula shown in formula (A):其中inR 1、R 1’、R 2、R 2’相同或不同的分别为氢、取代或未取代的C6-20的芳基、取代或未取代的C4-20的杂环基、取代或未取代的C1-20的烃氧基、取代或未取代的C1-20的烷基、取代或未取代的C3-20的环烷基、卤素、-Bn、-CF 3、-NO 2、取代氨基中的至少一种; R 1 , R 1' , R 2 , R 2' which are the same or different are hydrogen, substituted or unsubstituted C6-20 aryl, substituted or unsubstituted C4-20 heterocyclyl, substituted or unsubstituted, respectively C1-20 alkoxy, substituted or unsubstituted C1-20 alkyl, substituted or unsubstituted C3-20 cycloalkyl, halogen, -Bn, -CF 3 , -NO 2 , substituted amino at least one of;R 3为氢、取代或未取代的C6-20的芳基、取代或未取代的C4-20的杂环基、取代或未取代的C1-20的烷基、取代或未取代的C3-20的环烷基、取代氨基中的任意一种; R 3 is hydrogen, substituted or unsubstituted C6-20 aryl, substituted or unsubstituted C4-20 heterocyclyl, substituted or unsubstituted C1-20 alkyl, substituted or unsubstituted C3-20 Any of the cycloalkyl and substituted amino groups;X为-Cl、-Br、-I、CH 3COO-、CF 3COO-、-BF 4、-PF 6、-SbF 6、-OTf中的一种。 X is one of -Cl, -Br, -I, CH 3 COO-, CF 3 COO-, -BF 4 , -PF 6 , -SbF 6 , and -OTf.
- 一种大位阻氮杂环卡宾钯配合物,其特征在于该配合物是权利要求1所述式(A)化学结构式的化合物的对映体或消旋体,对映体具有式(B)所示化学结构式,消旋体具有式(C)所示化学结构式:A large sterically hindered nitrogen heterocyclic carbene palladium complex, characterized in that the complex is an enantiomer or a racemate of the compound of the formula (A) chemical structural formula described in claim 1, and the enantiomer has the formula (B) The chemical structural formula shown, the racemate has the chemical structural formula shown in formula (C):其中inR 1、R 1’、R 2、R 2’相同或不同的分别为氢、取代或未取代的C6-20的芳基、取代或未取代的C4-20的杂环基、取代或未取代的C1-20的烃氧基、取代或未取代的C1-20的烷基、取代或未取代的C3-20的环烷基、卤素、-Bn、-CF 3、-NO 2、取代氨基中的至少一种; R 1 , R 1' , R 2 , R 2' which are the same or different are hydrogen, substituted or unsubstituted C6-20 aryl, substituted or unsubstituted C4-20 heterocyclyl, substituted or unsubstituted, respectively C1-20 alkoxy, substituted or unsubstituted C1-20 alkyl, substituted or unsubstituted C3-20 cycloalkyl, halogen, -Bn, -CF 3 , -NO 2 , substituted amino at least one of;R 3为氢、取代或未取代的C6-20的芳基、取代或未取代的C4-20的杂环基、取代或未取代的C1-20的烷基、取代或未取代的C3-20的环烷基、取代氨基中的任意一种; R 3 is hydrogen, substituted or unsubstituted C6-20 aryl, substituted or unsubstituted C4-20 heterocyclyl, substituted or unsubstituted C1-20 alkyl, substituted or unsubstituted C3-20 Any of the cycloalkyl and substituted amino groups;X为-Cl、-Br、-I、CH 3COO-、CF 3COO-、-BF 4、-PF 6、-SbF 6、-OTf中的一种。 X is one of -Cl, -Br, -I, CH 3 COO-, CF 3 COO-, -BF 4 , -PF 6 , -SbF 6 , and -OTf.
- 根据权利要求1或2所述的大位阻氮杂环卡宾钯配合物,其特征在于:取代指基团中的一个或一个以上氢原子被C6-20的芳基、C4-20的杂环基、C1-20的烃氧基、C1-20的烷基、C3-20的环烷基、-CF 3、-NO 2、卤素基团取代。 The large sterically hindered nitrogen heterocyclic carbene palladium complex according to claim 1 or 2, wherein the substitution refers to that one or more hydrogen atoms in the group are replaced by C6-20 aryl, C4-20 heterocycle group, C1-20 hydrocarbyloxy group, C1-20 alkyl group, C3-20 cycloalkyl group, -CF 3 , -NO 2 , halogen group substitution.
- 一种权利要求1或2或3所述的大位阻氮杂环卡宾钯配合物的制备方法,其特征在于以苯基取代的大位阻咪唑盐为骨架,与官能团化的钯二聚体[Pd-(烯丙基-R 3)(u-X)] 2进行配位得到。 A kind of preparation method of the described large sterically hindered nitrogen heterocyclic carbene palladium complex of claim 1 or 2 or 3, it is characterized in that taking the large sterically hindered imidazolium salt substituted by phenyl as skeleton, and functionalized palladium dimer [Pd-(allyl-R 3 )(uX)] 2 is obtained by coordination.
- 根据权利要求4所述的大位阻氮杂环卡宾钯配合物的制备方法,其特征在于所述的大位阻咪唑盐为大位阻咪唑X代盐,其结构式如下:The preparation method of large sterically hindered nitrogen heterocyclic carbene palladium complex according to claim 4, it is characterized in that described large sterically hindered imidazole salt is large sterically hindered imidazole X generation salt, and its structural formula is as follows:其中,X为Cl、Br、I、CH 3COO、CF 3COO、BF 4、PF 6、SbF 6、OTf中的一种。 Wherein, X is one of Cl, Br, I, CH 3 COO, CF 3 COO, BF 4 , PF 6 , SbF 6 , and OTf.
- 根据权利要求4所述的大位阻氮杂环卡宾钯配合物的制备方法,其特征在于:所述的大位阻咪唑盐为大位阻咪唑X代盐,以取代或未取代的二苯基乙二胺为起始原料,与取代或未取代的2,6-二异丙基溴苯经C-N偶联反应,再与无机X代盐反应得到。The preparation method of large sterically hindered nitrogen heterocyclic carbene palladium complex according to claim 4, it is characterized in that: described large sterically hindered imidazole salt is large sterically hindered imidazole X-generation salt, with substituted or unsubstituted diphenyl Ethylenediamine is used as the starting material, and is obtained by C-N coupling reaction with substituted or unsubstituted 2,6-diisopropyl bromobenzene, and then reacting with inorganic X-substituted salt.
- 根据权利要求6所述的大位阻氮杂环卡宾钯配合物的制备方法,其特征在于:所述C-N偶联反应的反应温度为25-130℃,反应时间为1-96h;所述与无机X代盐反应的反应温度为25-120℃,反应时间为1-48h。The method for preparing a large sterically hindered nitrogen heterocyclic carbene palladium complex according to claim 6, wherein the reaction temperature of the C-N coupling reaction is 25-130°C, and the reaction time is 1-96h; The reaction temperature of the inorganic X-substituted salt reaction is 25-120°C, and the reaction time is 1-48h.
- 权利要求1或2或3所述的大位阻氮杂环卡宾钯配合物在催化C-N偶联反应中的应用。The application of the large sterically hindered nitrogen heterocyclic carbene palladium complex according to claim 1 or 2 or 3 in catalyzing C-N coupling reaction.
- 一种索尼吉布的合成方法,其特征在于以芳基/脂肪胺、芳基氯代物为反应物,钯催化体系,在碱性溶液条件下进行C-N偶联反应;A method for synthesizing Sony Gibb, which is characterized in that a C-N coupling reaction is carried out under alkaline solution conditions with aryl/aliphatic amine and aryl chloride as reactants and a palladium catalytic system;所述的钯催化体系包括单膦配体/钯催化体系、权利要求1或2或3所述的大位阻氮杂环卡宾钯配合物中的至少一种;所述单膦配体/钯催化体系中的单膦配体包括联苯类、联萘类、联芳类、吲哚类、咔唑类、二茂铁类、含有桥连侧链的联苯类单膦配体中的至少一种;所述单膦配体/钯催化体系中的钯包括PdCl 2、Pd(OAc) 2、Pd(dba) 2、Pd 2(dba) 3、Pd(PPh 3) 4、 Pd(PPh 3) 2Cl 2中的至少一种;所述偶联反应的温度为25-130℃,反应时间为1-96h;碱性溶液的碱为碳酸钠、碳酸钾、碳酸铯、氢氧化钾、氢氧化钠、叔丁醇钠、叔丁醇钾、磷酸钾中的至少一种;所述碱性溶液的溶剂包括二氧六环、乙二醇二甲醚、乙醚、甲基叔丁基醚、苯甲醚、四氢呋喃、2-甲基四氢呋喃、甲苯、间二甲苯、乙苯、均三甲苯、C1-C5醇、二甲基甲酰胺、二甲基乙酰胺、DMSO、乙腈、水或其两种或两种以上的混合溶剂的组合。 The palladium catalytic system comprises at least one of the monophosphine ligand/palladium catalytic system and the large sterically hindered nitrogen heterocyclic carbene palladium complex described in claim 1 or 2 or 3; the monophosphine ligand/palladium The monophosphine ligands in the catalytic system include at least biphenyls, binaphthyls, biaryls, indoles, carbazoles, ferrocenes, and biphenyl monophosphine ligands containing bridged side chains. One; palladium in the monophosphine ligand/palladium catalytic system includes PdCl 2 , Pd(OAc) 2 , Pd(dba) 2 , Pd 2 (dba) 3 , Pd(PPh 3 ) 4 , Pd(PPh 3 ) 2 Cl 2 at least one; the temperature of the coupling reaction is 25-130 ° C, and the reaction time is 1-96 h; the alkali of the alkaline solution is sodium carbonate, potassium carbonate, cesium carbonate, potassium hydroxide, hydrogen At least one of sodium oxide, sodium tert-butoxide, potassium tert-butoxide, potassium phosphate; the solvent of the alkaline solution includes dioxane, ethylene glycol dimethyl ether, diethyl ether, methyl tert-butyl ether, Anisole, tetrahydrofuran, 2-methyltetrahydrofuran, toluene, m-xylene, ethylbenzene, mesitylene, C1-C5 alcohols, dimethylformamide, dimethylacetamide, DMSO, acetonitrile, water or both A combination of one or more mixed solvents.
- 根据权利要求9所述的合成方法,其特征在于具体为,3-溴-2-甲基苯甲酸与4-(三氟甲氧基)苯硼酸进行Suzuki偶联反应,制得联苯中间体2-甲基-3-(三氟甲氧基苯基)-苯甲酸,然后与5-氨基-2-氯吡啶进行缩合反应,制得酰胺中间体,在单膦配体/钯催化体系、权利要求1或2或3所述的大位阻氮杂环卡宾钯配合物的至少一种催化下,与2,6-二甲基吗啉进行C-N偶联反应,制得最终产物索尼吉布。synthetic method according to claim 9, is characterized in that, specifically, 3-bromo-2-methylbenzoic acid and 4-(trifluoromethoxy) benzeneboronic acid carry out Suzuki coupling reaction, make biphenyl intermediate 2-methyl-3-(trifluoromethoxyphenyl)-benzoic acid, then condensation reaction with 5-amino-2-chloropyridine to obtain an amide intermediate, which is prepared in a monophosphine ligand/palladium catalytic system, Carry out C-N coupling reaction with 2,6-dimethylmorpholine under at least one catalysis of the large sterically hindered nitrogen heterocyclic carbene palladium complex according to claim 1 or 2 or 3 to obtain the final product Sony Gibb .
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011094236.8A CN112209972A (en) | 2020-10-14 | 2020-10-14 | Large-steric-hindrance N-heterocyclic carbene-palladium complex, preparation method and application thereof, and synthetic method of sonchibu based on complex |
CN202011094236.8 | 2020-10-14 | ||
CN202111086054.0 | 2021-09-16 | ||
CN202111086054.0A CN113788859B (en) | 2020-10-14 | 2021-09-16 | Large-steric-hindrance N-heterocyclic carbene-palladium complex, preparation method and application thereof, and synthetic method of sonchibu based on complex |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022078306A1 true WO2022078306A1 (en) | 2022-04-21 |
Family
ID=74053384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2021/123160 WO2022078306A1 (en) | 2020-10-14 | 2021-10-12 | Large steric hinderance palladium-nitrogen-heterocyclic carbene complex, preparation method for same, applications of same, and synthesis method for sonidegib based on same |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN112209972A (en) |
WO (1) | WO2022078306A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115536817A (en) * | 2022-09-30 | 2022-12-30 | 武汉工程大学 | Naphthyl-substituted asymmetric metal catalyst and preparation method and application thereof |
CN115722266A (en) * | 2022-11-24 | 2023-03-03 | 广东药科大学 | Novel aza-carbene-amido-ruthenium catalyst and preparation method and application thereof |
CN118002197A (en) * | 2024-04-10 | 2024-05-10 | 山东新和成药业有限公司 | Palladium catalyst and preparation method and application thereof |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112209972A (en) * | 2020-10-14 | 2021-01-12 | 中山大学 | Large-steric-hindrance N-heterocyclic carbene-palladium complex, preparation method and application thereof, and synthetic method of sonchibu based on complex |
CN114146729B (en) * | 2021-11-16 | 2023-01-17 | 大赛璐(中国)投资有限公司 | Bidentate carbene catalyst carrier and heterogeneous catalyst |
CN114524812A (en) * | 2022-03-18 | 2022-05-24 | 湖南凯铂生物药业有限公司 | Crystal form preparation and synthesis method of 1, 4-dihydro-1, 6-naphthyridine compound |
CN115536818B (en) * | 2022-09-30 | 2024-11-08 | 武汉工程大学 | Pyrenyl-based N-heterocyclic carbene metal palladium catalyst and preparation method and application thereof |
CN116332964B (en) * | 2022-10-30 | 2024-05-24 | 西北大学 | Synthesis method of bidentate pyrazolyl nitrogen heterocyclic palladium carbene compound |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109293649A (en) * | 2018-11-12 | 2019-02-01 | 新发药业有限公司 | A kind of preparation method of Sony's Ji cloth intermediate and Sony's Ji cloth |
CN112209972A (en) * | 2020-10-14 | 2021-01-12 | 中山大学 | Large-steric-hindrance N-heterocyclic carbene-palladium complex, preparation method and application thereof, and synthetic method of sonchibu based on complex |
-
2020
- 2020-10-14 CN CN202011094236.8A patent/CN112209972A/en active Pending
-
2021
- 2021-09-16 CN CN202111086054.0A patent/CN113788859B/en active Active
- 2021-10-12 WO PCT/CN2021/123160 patent/WO2022078306A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109293649A (en) * | 2018-11-12 | 2019-02-01 | 新发药业有限公司 | A kind of preparation method of Sony's Ji cloth intermediate and Sony's Ji cloth |
CN112209972A (en) * | 2020-10-14 | 2021-01-12 | 中山大学 | Large-steric-hindrance N-heterocyclic carbene-palladium complex, preparation method and application thereof, and synthetic method of sonchibu based on complex |
Non-Patent Citations (4)
Title |
---|
LUAN XINJUN, WU LINGLIN, DRINKEL EMMA, MARIZ RONALDO, GATTI MICHELE, DORTA RETO: "Highly Chemo- and Enantioselective Synthesis of 3-Allyl-3-aryl Oxindoles via the Direct Palladium-Catalyzed α-Arylation of Amides", ORGANIC LETTERS, AMERICAN CHEMICAL SOCIETY, US, vol. 12, no. 9, 7 May 2010 (2010-05-07), US , pages 1912 - 1915, XP055921145, ISSN: 1523-7060, DOI: 10.1021/ol1003093 * |
OUYANG JIA-SHENG, LIU SIQI, PAN BENDU, ZHANG YAQI, LIANG HAO, CHEN BIN, HE XIAOBO, CHAN WESLEY TING KWOK, CHAN ALBERT S. C., SUN T: "A Bulky and Electron-Rich N -Heterocyclic Carbene–Palladium Complex (SIPr) Ph 2 Pd(cin)Cl: Highly Efficient and Versatile for the Buchwald–Hartwig Amination of (Hetero)aryl Chlorides with (Hetero)aryl Amines at Room Temperature", ACS CATALYSIS, AMERICAN CHEMICAL SOCIETY, US, vol. 11, no. 15, 6 August 2021 (2021-08-06), US , pages 9252 - 9261, XP055921142, ISSN: 2155-5435, DOI: 10.1021/acscatal.1c01929 * |
SUSANNE M. PODHAJSKY; YASUMASA IWAI; AMANDA COOK-SNEATHEN; MATTHEW S. SIGMAN;: "Asymmetric palladium-catalyzed hydroarylation of styrenes and dienes", TETRAHEDRON, ELSEVIER SIENCE PUBLISHERS, AMSTERDAM, NL, vol. 67, no. 24, 11 February 2011 (2011-02-11), AMSTERDAM, NL , pages 4435 - 4441, XP028216330, ISSN: 0040-4020, DOI: 10.1016/j.tet.2011.02.027 * |
XU LIANG, SHI YIAN: "Chiral N -Heterocyclic Carbene−Pd(0)-Catalyzed Asymmetric Diamination of Conjugated Dienes and Triene", THE JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY, vol. 73, no. 2, 1 January 2008 (2008-01-01), pages 749 - 751, XP055921143, ISSN: 0022-3263, DOI: 10.1021/jo702167u * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115536817A (en) * | 2022-09-30 | 2022-12-30 | 武汉工程大学 | Naphthyl-substituted asymmetric metal catalyst and preparation method and application thereof |
CN115722266A (en) * | 2022-11-24 | 2023-03-03 | 广东药科大学 | Novel aza-carbene-amido-ruthenium catalyst and preparation method and application thereof |
CN115722266B (en) * | 2022-11-24 | 2024-04-05 | 广东药科大学 | Azacarbene-amino-ruthenium catalyst, and preparation method and application thereof |
CN118002197A (en) * | 2024-04-10 | 2024-05-10 | 山东新和成药业有限公司 | Palladium catalyst and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN113788859B (en) | 2023-03-31 |
CN113788859A (en) | 2021-12-14 |
CN112209972A (en) | 2021-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022078306A1 (en) | Large steric hinderance palladium-nitrogen-heterocyclic carbene complex, preparation method for same, applications of same, and synthesis method for sonidegib based on same | |
US7858784B2 (en) | Ligands for transition-metal-catalyzed cross-couplings, and methods of use thereof | |
EP1027316A1 (en) | Synthesis of aryl ethers, methods and reagents related thereto | |
CN108640869B (en) | Transition metal catalyzed C-H coupling high-efficiency preparation of o-amidated aryl heterocyclic derivatives | |
CN112916042B (en) | Chiral quaternary ammonium salt phase transfer catalyst based on tetramethyl spiroindane skeleton and preparation method thereof | |
Lee et al. | Dimetallic palladium‐NHC complexes: synthesis, characterization, and catalytic application for direct C− H arylation reaction of heteroaromatics with aryl chlorides | |
CN110117237A (en) | A kind of preparation method of aromatic nitriles or alkenyl nitrile compounds | |
Hau et al. | Enantioselective Brønsted base catalyzed [4+ 2] cycloaddition using novel amino-substituted tetraphenylene derivatives | |
CN105367481B (en) | A kind of synthetic method of bis- fluoro- 2- oxoindole derivatives of 3,3- | |
CN109810147B (en) | Pyrene-labeled benzimidazole nitrogen heterocyclic carbene palladium metal complex, and preparation and application thereof | |
CN103748065B (en) | The manufacture method of 2-alkenyl amine compound | |
JP4360096B2 (en) | Optically active quaternary ammonium salt, method for producing the same, and method for producing optically active α-amino acid derivative using the same as phase transfer catalyst | |
CN102153483B (en) | Axial chirality vicinal diamine compound and preparation method thereof | |
KR101614887B1 (en) | Method for preparation of amide and imide from alcohol and nitrogen Containing Compound | |
JP6461942B2 (en) | Monoarylation of aromatic amines. | |
CN110684043B (en) | C-N axis chiral arylamine compound and preparation method thereof | |
Raju et al. | Copper complexes for the chemoselective N-arylation of arylamines and sulfanilamides via Chan–Evans–Lam cross-coupling | |
CN109053556A (en) | Pyridyl group bridging-phenyl-amino pyridine compounds and their, complex and its synthesis and application | |
CN106083649B (en) | A kind of synthetic method of the Cyclohexadiene derivatives of 3,5 diaryl, 2,6,6 tricyano, 1 imino group 2,4 | |
CN113234083B (en) | Tetrahydroquinoline pyran compound and preparation method and application thereof | |
JP2021502885A (en) | Phosphine-free cobalt-based catalysts and methods and uses for their preparation | |
Kumar et al. | Synthesis of Axially Chiral Biaryls via Pd (II)-Catalysed Direct C (sp2)-H Olefination and Arylation | |
AU2018367119B2 (en) | Process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides | |
McGovern | Enantioselective cross-coupling of monosubstituted ferrocenes in chiral ionic liquids | |
Davalos-Morinigo | N-Heterocyclic Carbene Containing Macrocycles: Design, Synthesis and Applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21879350 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21879350 Country of ref document: EP Kind code of ref document: A1 |